| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | malate dehydrogenase activity | 2.26e-06 | 8 | 272 | 4 | GO:0016615 | |
| GeneOntologyMolecularFunction | malate dehydrogenase (decarboxylating) (NADP+) activity | 2.50e-06 | 3 | 272 | 3 | GO:0004473 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | GPHN ATR PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 IDNK BLK PIK3R4 CKMT2 FCSK NEK1 BMX DLG1 NAGK DTYMK KSR2 MAP3K14 NEK7 OAS2 REV3L LCK MTOR NIM1K NT5C2 TNK2 PRKG1 PRKG2 POLQ | 4.93e-06 | 938 | 272 | 31 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase activity | ATR PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 IDNK BLK PIK3R4 CKMT2 FCSK NEK1 BMX DLG1 NAGK DTYMK KSR2 MAP3K14 NEK7 LCK MTOR NIM1K NT5C2 TNK2 PRKG1 PRKG2 | 6.33e-06 | 764 | 272 | 27 | GO:0016301 |
| GeneOntologyMolecularFunction | malic enzyme activity | 9.90e-06 | 4 | 272 | 3 | GO:0004470 | |
| GeneOntologyMolecularFunction | oxaloacetate decarboxylase activity | 9.90e-06 | 4 | 272 | 3 | GO:0008948 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 2.00e-05 | 138 | 272 | 10 | GO:0016614 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH9 ABCA9 ABCB4 IFIH1 UBA1 ABCD3 DDX23 KIFC3 CARNS1 HSPA9 DNHD1 DYNC2H1 MYO18A MSH5 SMC2 ATP6V0D1 DNAH17 DYNC1LI1 ACIN1 MACF1 POLQ ATP5F1B | 3.84e-05 | 614 | 272 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ATR PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 IDNK BLK PIK3R4 FCSK NEK1 BMX NAGK KSR2 MAP3K14 NEK7 LCK MTOR NIM1K NT5C2 TNK2 PRKG1 PRKG2 | 4.21e-05 | 709 | 272 | 24 | GO:0016773 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.87e-05 | 18 | 272 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | malate dehydrogenase (decarboxylating) (NAD+) activity | 1.85e-04 | 2 | 272 | 2 | GO:0004471 | |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 1.85e-04 | 2 | 272 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | cGMP-dependent protein kinase activity | 1.85e-04 | 2 | 272 | 2 | GO:0004692 | |
| GeneOntologyMolecularFunction | lipoic acid binding | 1.85e-04 | 2 | 272 | 2 | GO:0031405 | |
| GeneOntologyMolecularFunction | protein kinase activity | ATR PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 BLK PIK3R4 NEK1 BMX KSR2 MAP3K14 NEK7 LCK MTOR NIM1K TNK2 PRKG1 PRKG2 | 2.27e-04 | 600 | 272 | 20 | GO:0004672 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN RAB11B MYH9 HIP1 CFL2 RAB11A TUBGCP4 MAP3K1 WASH6P CGN DLG1 DLG4 KIFC3 CORO7 MLPH DIP2B CLIP2 TOGARAM2 MYO18A KPTN WASH3P CLIP3 PPP2R2A MYLIP MACF1 AATF LIMCH1 EML1 CROCC SNTB1 | 2.34e-04 | 1099 | 272 | 30 | GO:0008092 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ATR PAK4 STK38 ACVR1B ACVR2A MAP3K1 PIK3R4 NEK1 KSR2 MAP3K14 NEK7 MTOR NIM1K TNK2 PRKG1 PRKG2 | 4.36e-04 | 446 | 272 | 16 | GO:0004674 |
| GeneOntologyMolecularFunction | NAD binding | 4.79e-04 | 73 | 272 | 6 | GO:0051287 | |
| GeneOntologyMolecularFunction | ADP binding | 4.80e-04 | 48 | 272 | 5 | GO:0043531 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | ATR PAK4 STK38 MAP3K1 PIK3R4 NEK1 KSR2 MAP3K14 NEK7 MTOR NIM1K TNK2 PRKG1 PRKG2 | 4.87e-04 | 363 | 272 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 5.02e-04 | 12 | 272 | 3 | GO:0016174 | |
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 5.02e-04 | 12 | 272 | 3 | GO:0008239 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.33e-04 | 28 | 272 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | GPHN CYP2A6 DBT ME1 ME2 PHGDH ME3 ADH4 DUOX1 DHODH ALDH3A2 D2HGDH HSD17B7 FMO5 MTHFD1L ACAD9 CBR1 PDHX CRYZ MECR AIFM1 HAO2 | 8.46e-04 | 766 | 272 | 22 | GO:0016491 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 9.79e-04 | 56 | 272 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor | 1.09e-03 | 4 | 272 | 2 | GO:0016899 | |
| GeneOntologyMolecularFunction | NADPH:quinone reductase activity | 1.09e-03 | 4 | 272 | 2 | GO:0003960 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.09e-03 | 4 | 272 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.17e-03 | 118 | 272 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | cGMP binding | 1.23e-03 | 16 | 272 | 3 | GO:0030553 | |
| GeneOntologyMolecularFunction | carboxy-lyase activity | 1.41e-03 | 36 | 272 | 4 | GO:0016831 | |
| GeneOntologyMolecularFunction | NADP binding | 1.55e-03 | 62 | 272 | 5 | GO:0050661 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.80e-03 | 127 | 272 | 7 | GO:0016616 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 1.80e-03 | 5 | 272 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | inhibin binding | 1.80e-03 | 5 | 272 | 2 | GO:0034711 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.81e-03 | 94 | 272 | 6 | GO:0050660 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.91e-03 | 95 | 272 | 6 | GO:0016651 | |
| GeneOntologyBiologicalProcess | malate metabolic process | 3.44e-06 | 9 | 270 | 4 | GO:0006108 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.26e-05 | 40 | 270 | 6 | GO:0097242 | |
| GeneOntologyBiologicalProcess | cell junction organization | GPHN MYH9 MYCBP2 INSR STK38 MPDZ MDGA2 SIX4 CCM2 CGN MTMR2 DLG1 C3 DLG4 NLGN2 KIFC3 BSN CX3CL1 NPTX1 CUX2 WNT7B GRID2 PLXNC1 PLXNA4 LRP4 MACF1 TNF GRIP2 LIMCH1 CACNA2D3 | 1.28e-05 | 974 | 270 | 30 | GO:0034330 |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP2A6 ACACB INSR ME1 ME2 PHGDH ME3 IDNK ADH4 FBP1 ABCD3 C3 ALDH3A2 ILVBL APOA5 MTHFD1L ACAD9 CBR1 PDHX MLYCD MECR MTOR C1QTNF9 HAO2 | 3.65e-05 | 731 | 270 | 24 | GO:0032787 |
| GeneOntologyBiologicalProcess | synapse organization | GPHN MYCBP2 INSR STK38 MDGA2 SIX4 MTMR2 DLG1 C3 DLG4 NLGN2 BSN CX3CL1 NPTX1 CUX2 WNT7B GRID2 PLXNC1 PLXNA4 LRP4 TNF GRIP2 CACNA2D3 | 3.78e-05 | 685 | 270 | 23 | GO:0050808 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | CYP2A6 ACACB MAT1A INSR DBT ME1 ME2 HNMT PHGDH ME3 IDNK ADH4 FBP1 ABCD3 C3 ALDH3A2 CARNS1 D2HGDH ILVBL NAGK APOA5 MTHFD1L ACAD9 CBR1 PDHX MLYCD MECR MTOR C1QTNF9 HAO2 | 4.01e-05 | 1035 | 270 | 30 | GO:0019752 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 5.47e-05 | 130 | 270 | 9 | GO:1905477 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | CYP2A6 ACACB MAT1A INSR DBT ME1 ME2 HNMT PHGDH ME3 IDNK ADH4 FBP1 ABCD3 C3 ALDH3A2 CARNS1 D2HGDH ILVBL NAGK APOA5 MTHFD1L ACAD9 CBR1 PDHX MLYCD MECR MTOR C1QTNF9 HAO2 | 5.98e-05 | 1058 | 270 | 30 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | CYP2A6 ACACB MAT1A INSR DBT ME1 ME2 HNMT PHGDH ME3 IDNK ADH4 FBP1 ABCD3 C3 ALDH3A2 CARNS1 D2HGDH ILVBL NAGK APOA5 MTHFD1L ACAD9 CBR1 PDHX MLYCD MECR MTOR C1QTNF9 HAO2 | 6.62e-05 | 1064 | 270 | 30 | GO:0006082 |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 7.91e-05 | 79 | 270 | 7 | GO:0034394 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | CYP2A6 ACACB MAT1A INSR ACVR2A DBT HNMT IDNK ADH4 PIK3R4 LRIG2 WASH6P DUOX1 NOD1 SUPT5H ABCD3 MTMR2 CARNS1 ILVBL NAGK APOA5 MLYCD WASH3P VPS13D CRYZ ATP6V0D1 MTOR MYLIP LRP4 SLC7A5 TNF WDFY3 HAO2 | 1.04e-04 | 1253 | 270 | 33 | GO:0044248 |
| GeneOntologyBiologicalProcess | receptor clustering | 1.08e-04 | 83 | 270 | 7 | GO:0043113 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 1.37e-04 | 115 | 270 | 8 | GO:0035418 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MYH9 RAB11A TUBGCP4 WASH6P CGN DLG1 KATNIP GNAI1 KIFC3 BSN DNHD1 CLIP2 DYNC2H1 TOGARAM2 NEK7 TACC2 CEP192 MADD WASH3P CLIP3 DNAAF10 DNAH17 DYNC1LI1 MACF1 IFT122 EML1 CROCC CFAP44 HYDIN | 1.43e-04 | 1058 | 270 | 29 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | GPHN RAB11A WASH6P DLG1 DLG4 GNAI1 HECTD1 NPTX1 DPP10 WASH3P CLIP3 LRP6 MACF1 TNF GRIP2 PRKG2 | 1.52e-04 | 422 | 270 | 16 | GO:1990778 |
| GeneOntologyBiologicalProcess | external genitalia morphogenesis | 1.71e-04 | 2 | 270 | 2 | GO:0035261 | |
| GeneOntologyBiologicalProcess | neurotransmitter-gated ion channel clustering | 1.74e-04 | 22 | 270 | 4 | GO:0072578 | |
| GeneOntologyBiologicalProcess | spindle organization | MYH9 RAB11A TUBGCP4 WASH6P DLG1 GNAI1 NEK7 TACC2 CEP192 WASH3P EML1 | 1.88e-04 | 224 | 270 | 11 | GO:0007051 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MYH9 CFL2 RAB11A DCC MAP3K1 WASH6P DLG1 CX3CL1 DIP2B WNT7B WASH3P GUCY1A1 MTOR C1QTNF9 PLXNA4 MACF1 TNF GRIP2 PRKG1 PRKG2 | 1.99e-04 | 618 | 270 | 20 | GO:0090066 |
| GeneOntologyBiologicalProcess | fatty acid oxidation | 2.07e-04 | 122 | 270 | 8 | GO:0019395 | |
| GeneOntologyBiologicalProcess | cytoplasmic microtubule organization | 2.24e-04 | 66 | 270 | 6 | GO:0031122 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | GPHN ARL2BP ATR RAB11A SRP68 SIX4 RYR2 PIK3R4 GLMP HPS4 DLG1 DLG4 NIPBL KPNA1 NPTX1 DYNC2H1 SH3KBP1 NUP98 CEP192 KPTN WASH3P PPP2R2B VPS13D MTOR AIFM1 MACF1 AKAP11 IFT122 CROCC | 2.40e-04 | 1091 | 270 | 29 | GO:0033365 |
| GeneOntologyBiologicalProcess | endosome to plasma membrane protein transport | 2.48e-04 | 24 | 270 | 4 | GO:0099638 | |
| GeneOntologyBiologicalProcess | regulation of NADP metabolic process | 2.49e-04 | 10 | 270 | 3 | GO:1902031 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | ACACB MAT1A DBT HNMT IDNK ABCD3 CARNS1 ILVBL NAGK MLYCD MTOR HAO2 | 2.62e-04 | 272 | 270 | 12 | GO:0016054 |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | ACACB MAT1A DBT HNMT IDNK ABCD3 CARNS1 ILVBL NAGK MLYCD MTOR HAO2 | 2.62e-04 | 272 | 270 | 12 | GO:0046395 |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 7.33e-05 | 18 | 271 | 4 | GO:0000159 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 8.47e-05 | 56 | 271 | 6 | GO:0031234 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.57e-04 | 185 | 271 | 10 | GO:0009898 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | GPHN MPDZ DCC MTMR2 DLG1 PLEKHA5 DLG4 NLGN2 GNAI2 BSN KPNA1 SH3GL3 GRID2 PLXNC1 PLXNA4 LRP4 MACF1 GRIP2 | 1.76e-04 | 523 | 271 | 18 | GO:0098984 |
| GeneOntologyCellularComponent | excitatory synapse | 4.93e-04 | 107 | 271 | 7 | GO:0060076 | |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 4.98e-04 | 3 | 271 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | endocytic vesicle | RAB11B MYH9 RAB11A PIK3R4 NOD1 DLG4 WNT7B SH3KBP1 MYO18A HEATR5A LCK ATP6V0D1 MTOR DYNC1LI1 | 5.23e-04 | 384 | 271 | 14 | GO:0030139 |
| GeneOntologyCellularComponent | asymmetric synapse | GPHN MPDZ DCC MTMR2 DLG1 PLEKHA5 DLG4 BSN KPNA1 SH3GL3 GRID2 PLXNC1 PLXNA4 LRP4 MACF1 GRIP2 | 5.30e-04 | 477 | 271 | 16 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 7.86e-04 | 56 | 271 | 5 | GO:0099091 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 8.78e-04 | 230 | 271 | 10 | GO:0098562 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 8.78e-04 | 230 | 271 | 10 | GO:0019898 | |
| GeneOntologyCellularComponent | postsynaptic specialization | GPHN MPDZ DCC MTMR2 DLG1 PLEKHA5 DLG4 NLGN2 BSN KPNA1 SH3GL3 GRID2 LCK LRP4 MACF1 GRIP2 | 9.32e-04 | 503 | 271 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | microtubule organizing center | ARL2BP RAB11A TUBGCP4 HNMT WASH6P NEK1 NLRC5 GNAI1 GNAI2 KIFC3 MLPH MYO18A NEK7 TACC2 CEP192 LCK WASH3P ATP6V0D1 DYNC1LI1 AKAP11 IFT122 CROCC CDC27 PDZD2 | 9.34e-04 | 919 | 271 | 24 | GO:0005815 |
| GeneOntologyCellularComponent | HULC complex | 9.88e-04 | 4 | 271 | 2 | GO:0033503 | |
| GeneOntologyCellularComponent | myosin complex | 9.98e-04 | 59 | 271 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | glutamatergic synapse | HIP1 RAB11A STK38 MPDZ MDGA2 KCNJ4 DLG1 PLEKHA5 DLG4 BSN KPNA1 NPTX1 SH3GL3 GRID2 LCK PPP2R2A GUCY1A1 PLXNC1 MTOR PLXNA4 SLC17A8 GRIP2 | 1.03e-03 | 817 | 271 | 22 | GO:0098978 |
| GeneOntologyCellularComponent | phagocytic vesicle | 1.04e-03 | 157 | 271 | 8 | GO:0045335 | |
| GeneOntologyCellularComponent | centrosome | ARL2BP RAB11A TUBGCP4 HNMT WASH6P NEK1 NLRC5 GNAI1 GNAI2 KIFC3 NEK7 TACC2 CEP192 LCK WASH3P ATP6V0D1 DYNC1LI1 AKAP11 CROCC CDC27 PDZD2 | 1.14e-03 | 770 | 271 | 21 | GO:0005813 |
| GeneOntologyCellularComponent | cell cortex | MYH9 HIP1 RYR1 WASH6P DLG4 GNAI1 BSN MLPH CLIP2 WASH3P CLIP3 HMCN1 MACF1 | 1.18e-03 | 371 | 271 | 13 | GO:0005938 |
| GeneOntologyCellularComponent | somatodendritic compartment | GPHN INSR MPDZ EVX1 KCNJ4 DHODH MTMR2 DLG1 DLG4 NLGN2 GNAI2 BSN CX3CL1 MLPH CNGA4 KPNA1 DIP2B CLIP2 PTBP2 ACAD9 GRID2 MTOR SLC17A8 LRP4 LRP6 TNK2 TNF GRIP2 WDFY3 | 1.35e-03 | 1228 | 271 | 29 | GO:0036477 |
| GeneOntologyCellularComponent | mitochondrial matrix | ARL2BP TRIT1 ACACB DBT ME2 ME3 D2HGDH HSPA9 MTHFD1L DTYMK METTL4 PDHX MLYCD MECR CCAR2 ATP5F1B | 1.40e-03 | 523 | 271 | 16 | GO:0005759 |
| Domain | PP2A_PR55 | 4.21e-08 | 4 | 269 | 4 | IPR000009 | |
| Domain | PR55_2 | 4.21e-08 | 4 | 269 | 4 | PS01025 | |
| Domain | PR55_1 | 4.21e-08 | 4 | 269 | 4 | PS01024 | |
| Domain | PP2A_PR55_CS | 4.21e-08 | 4 | 269 | 4 | IPR018067 | |
| Domain | - | RAB11B TRIT1 RAB11A ABCA9 ABCB4 IDNK IFIH1 NOD1 ABCD3 NLRC5 DDX23 DLG1 DLG4 GNAI1 GNAI2 DNHD1 DYNC2H1 MTHFD1L DTYMK MYO18A MSH5 SMC2 ARL10 GIMAP8 MTIF2 DYNC1LI1 POLQ HYDIN ATP5F1B | 1.26e-06 | 746 | 269 | 29 | 3.40.50.300 |
| Domain | P-loop_NTPase | RAB11B TRIT1 MYH9 RAB11A ABCA9 ABCB4 IDNK IFIH1 NOD1 ABCD3 NLRC5 DDX23 DLG1 DLG4 GNAI1 GNAI2 KIFC3 DNHD1 DYNC2H1 MTHFD1L DTYMK MYO18A MSH5 SMC2 ARL10 GIMAP8 MTIF2 DYNC1LI1 POLQ HYDIN ATP5F1B | 1.93e-06 | 848 | 269 | 31 | IPR027417 |
| Domain | Malic_OxRdtase | 2.95e-06 | 3 | 269 | 3 | IPR001891 | |
| Domain | MALIC_ENZYMES | 2.95e-06 | 3 | 269 | 3 | PS00331 | |
| Domain | Malic_M | 2.95e-06 | 3 | 269 | 3 | SM00919 | |
| Domain | - | 2.95e-06 | 3 | 269 | 3 | 3.40.50.10380 | |
| Domain | Malic_NAD-bd | 2.95e-06 | 3 | 269 | 3 | IPR012302 | |
| Domain | Malic_N_dom | 2.95e-06 | 3 | 269 | 3 | IPR012301 | |
| Domain | Malic_M | 2.95e-06 | 3 | 269 | 3 | PF03949 | |
| Domain | malic | 2.95e-06 | 3 | 269 | 3 | PF00390 | |
| Domain | malic | 2.95e-06 | 3 | 269 | 3 | SM01274 | |
| Domain | Malic_enzyme_CS | 2.95e-06 | 3 | 269 | 3 | IPR015884 | |
| Domain | - | ME1 ME2 PHGDH ME3 ADH4 UBA1 HSD17B7 FMO5 MTHFD1L CBR1 CRYZ MECR | 6.39e-06 | 169 | 269 | 12 | 3.40.50.720 |
| Domain | NAD(P)-bd_dom | ME1 ME2 PHGDH ME3 ADH4 UBA1 HSD17B7 FMO5 MTHFD1L CBR1 CRYZ MECR | 8.12e-06 | 173 | 269 | 12 | IPR016040 |
| Domain | PDZ | HTRA1 SIPA1L3 MPDZ DLG1 DLG4 ARHGAP23 MYO18A GRIP2 SNTB1 PDZD2 | 3.83e-05 | 141 | 269 | 10 | PF00595 |
| Domain | Kinase-like_dom | ATR PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 BLK PIK3R4 NEK1 BMX KSR2 MAP3K14 NEK7 LCK MTOR NIM1K MACF1 TNK2 PRKG1 PRKG2 | 4.13e-05 | 542 | 269 | 21 | IPR011009 |
| Domain | PDZ | HTRA1 SIPA1L3 MPDZ DLG1 DLG4 ARHGAP23 MYO18A GRIP2 SNTB1 PDZD2 | 5.79e-05 | 148 | 269 | 10 | SM00228 |
| Domain | - | HTRA1 SIPA1L3 MPDZ DLG1 DLG4 ARHGAP23 MYO18A GRIP2 SNTB1 PDZD2 | 6.48e-05 | 150 | 269 | 10 | 2.30.42.10 |
| Domain | PDZ | HTRA1 SIPA1L3 MPDZ DLG1 DLG4 ARHGAP23 MYO18A GRIP2 SNTB1 PDZD2 | 6.86e-05 | 151 | 269 | 10 | PS50106 |
| Domain | PDZ | HTRA1 SIPA1L3 MPDZ DLG1 DLG4 ARHGAP23 MYO18A GRIP2 SNTB1 PDZD2 | 7.25e-05 | 152 | 269 | 10 | IPR001478 |
| Domain | cGMP_dep_kinase | 2.07e-04 | 2 | 269 | 2 | IPR002374 | |
| Domain | ADOMET_SYNTHASE_CS | 2.07e-04 | 2 | 269 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 2.07e-04 | 2 | 269 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 2.07e-04 | 2 | 269 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 2.07e-04 | 2 | 269 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 2.07e-04 | 2 | 269 | 2 | IPR022628 | |
| Domain | S-AdoMet_synt_N | 2.07e-04 | 2 | 269 | 2 | PF00438 | |
| Domain | S-AdoMet_synthetase | 2.07e-04 | 2 | 269 | 2 | IPR002133 | |
| Domain | S-AdoMet_synt_M | 2.07e-04 | 2 | 269 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 2.07e-04 | 2 | 269 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_1 | 2.07e-04 | 2 | 269 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 2.07e-04 | 2 | 269 | 2 | PS00377 | |
| Domain | Biotin_lipoyl | 2.33e-04 | 9 | 269 | 3 | PF00364 | |
| Domain | Prot_kinase_dom | PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 BLK PIK3R4 NEK1 BMX KSR2 MAP3K14 NEK7 LCK NIM1K TNK2 PRKG1 PRKG2 | 2.75e-04 | 489 | 269 | 18 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 BLK PIK3R4 NEK1 BMX KSR2 MAP3K14 NEK7 LCK NIM1K TNK2 PRKG1 PRKG2 | 3.04e-04 | 493 | 269 | 18 | PS50011 |
| Domain | BIOTINYL_LIPOYL | 3.29e-04 | 10 | 269 | 3 | PS50968 | |
| Domain | Biotin_lipoyl | 3.29e-04 | 10 | 269 | 3 | IPR000089 | |
| Domain | - | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C PLXNC1 DNAAF10 PLXNA4 IFT122 WDFY3 EML1 CFAP44 | 3.56e-04 | 333 | 269 | 14 | 2.130.10.10 |
| Domain | PROTEIN_KINASE_ATP | PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 BLK PIK3R4 NEK1 BMX MAP3K14 NEK7 LCK NIM1K TNK2 PRKG1 PRKG2 | 3.78e-04 | 459 | 269 | 17 | PS00107 |
| Domain | WD40/YVTN_repeat-like_dom | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C PLXNC1 DNAAF10 PLXNA4 IFT122 WDFY3 EML1 CFAP44 | 3.78e-04 | 335 | 269 | 14 | IPR015943 |
| Domain | Protein_kinase_ATP_BS | PAK4 INSR STK38 ACVR1B MAP3K1 BLK NEK1 BMX MAP3K14 NEK7 LCK NIM1K TNK2 PRKG1 PRKG2 | 4.19e-04 | 379 | 269 | 15 | IPR017441 |
| Domain | WD40 | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 5.36e-04 | 268 | 269 | 12 | SM00320 |
| Domain | Single_hybrid_motif | 5.90e-04 | 12 | 269 | 3 | IPR011053 | |
| Domain | WD40_repeat | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 6.10e-04 | 272 | 269 | 12 | IPR001680 |
| Domain | E3_binding | 6.14e-04 | 3 | 269 | 2 | PF02817 | |
| Domain | E3-bd | 6.14e-04 | 3 | 269 | 2 | IPR004167 | |
| Domain | FAD-linked_oxidase_C | 6.14e-04 | 3 | 269 | 2 | IPR004113 | |
| Domain | FAD-oxidase_C | 6.14e-04 | 3 | 269 | 2 | PF02913 | |
| Domain | RyR | 6.14e-04 | 3 | 269 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 6.14e-04 | 3 | 269 | 2 | PF06459 | |
| Domain | Ryan_recept | 6.14e-04 | 3 | 269 | 2 | IPR013333 | |
| Domain | Ryanodine_rcpt | 6.14e-04 | 3 | 269 | 2 | IPR003032 | |
| Domain | - | 6.14e-04 | 3 | 269 | 2 | 4.10.320.10 | |
| Domain | Ryanrecept_TM4-6 | 6.14e-04 | 3 | 269 | 2 | IPR009460 | |
| Domain | FAD-linked_Oxase-like_C | 6.14e-04 | 3 | 269 | 2 | IPR016164 | |
| Domain | Vanillyl_alc_oxidase_C-sub2 | 6.14e-04 | 3 | 269 | 2 | IPR016171 | |
| Domain | WD_REPEATS_1 | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 7.39e-04 | 278 | 269 | 12 | PS00678 |
| Domain | WD_REPEATS_2 | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 7.63e-04 | 279 | 269 | 12 | PS50082 |
| Domain | WD_REPEATS_REGION | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 7.63e-04 | 279 | 269 | 12 | PS50294 |
| Domain | CAT-like_dom | 1.22e-03 | 4 | 269 | 2 | IPR023213 | |
| Domain | FAD_binding_4 | 1.22e-03 | 4 | 269 | 2 | PF01565 | |
| Domain | DLG1_PEST_dom | 1.22e-03 | 4 | 269 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 1.22e-03 | 4 | 269 | 2 | IPR019583 | |
| Domain | 2-oxoacid_dh | 1.22e-03 | 4 | 269 | 2 | PF00198 | |
| Domain | 2-oxoacid_DH_actylTfrase | 1.22e-03 | 4 | 269 | 2 | IPR001078 | |
| Domain | Neural_cell_adh | 1.22e-03 | 4 | 269 | 2 | IPR009138 | |
| Domain | MAGUK_N_PEST | 1.22e-03 | 4 | 269 | 2 | PF10608 | |
| Domain | PDZ_assoc | 1.22e-03 | 4 | 269 | 2 | PF10600 | |
| Domain | Oxid_FAD_bind_N | 1.22e-03 | 4 | 269 | 2 | IPR006094 | |
| Domain | MAGUK_N_PEST | 1.22e-03 | 4 | 269 | 2 | SM01277 | |
| Domain | DLG1 | 1.22e-03 | 4 | 269 | 2 | IPR016313 | |
| Domain | - | 1.22e-03 | 4 | 269 | 2 | 3.30.559.10 | |
| Domain | WD40_repeat_dom | PPP2R2D PIK3R4 MIOS CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 1.31e-03 | 297 | 269 | 12 | IPR017986 |
| Domain | ConA-like_dom | 1.33e-03 | 219 | 269 | 10 | IPR013320 | |
| Domain | WD40 | PPP2R2D PIK3R4 CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 1.39e-03 | 259 | 269 | 11 | PF00400 |
| Domain | ADH_N | 1.44e-03 | 16 | 269 | 3 | PF08240 | |
| Domain | PKS_ER | 1.44e-03 | 16 | 269 | 3 | SM00829 | |
| Domain | cNMP-bd_CS | 1.44e-03 | 16 | 269 | 3 | IPR018488 | |
| Domain | PKS_ER | 1.44e-03 | 16 | 269 | 3 | IPR020843 | |
| Domain | ADH_N | 1.44e-03 | 16 | 269 | 3 | IPR013154 | |
| Domain | - | ATR PIK3R4 HECTD1 NIPBL KPNA1 TOGARAM2 HEATR5A MTOR SERAC1 WDFY3 | 1.47e-03 | 222 | 269 | 10 | 1.25.10.10 |
| Domain | PHR | 2.01e-03 | 5 | 269 | 2 | IPR012983 | |
| Domain | - | 2.01e-03 | 5 | 269 | 2 | 3.30.43.10 | |
| Domain | LIPOYL | 2.01e-03 | 5 | 269 | 2 | PS00189 | |
| Domain | 2-oxoA_DH_lipoyl-BS | 2.01e-03 | 5 | 269 | 2 | IPR003016 | |
| Domain | HnRNP-L/PTB | 2.01e-03 | 5 | 269 | 2 | IPR006536 | |
| Domain | PHR | 2.01e-03 | 5 | 269 | 2 | PF08005 | |
| Domain | FAD-bd_2_sub1 | 2.01e-03 | 5 | 269 | 2 | IPR016167 | |
| Domain | FATC | 2.01e-03 | 5 | 269 | 2 | PF02260 | |
| Domain | - | 2.05e-03 | 18 | 269 | 3 | 3.90.180.10 | |
| Domain | Myosin_tail_1 | 2.05e-03 | 18 | 269 | 3 | PF01576 | |
| Domain | Myosin_tail | 2.05e-03 | 18 | 269 | 3 | IPR002928 | |
| Domain | Ser/Thr_kinase_AS | PAK4 STK38 ACVR1B ACVR2A MAP3K1 PIK3R4 NEK1 KSR2 MAP3K14 NEK7 NIM1K PRKG1 PRKG2 | 2.11e-03 | 357 | 269 | 13 | IPR008271 |
| Domain | S_TKc | PAK4 STK38 ACVR1B ACVR2A MAP3K1 PIK3R4 NEK1 KSR2 MAP3K14 NEK7 NIM1K PRKG1 PRKG2 | 2.21e-03 | 359 | 269 | 13 | SM00220 |
| Domain | PROTEIN_KINASE_ST | PAK4 STK38 ACVR1B ACVR2A MAP3K1 PIK3R4 NEK1 KSR2 MAP3K14 NEK7 NIM1K PRKG1 PRKG2 | 2.38e-03 | 362 | 269 | 13 | PS00108 |
| Domain | ADH_zinc_N | 2.41e-03 | 19 | 269 | 3 | PF00107 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GPHN PPP2R2D MAT2A MPDZ SIX4 LRIG2 FAM120A PTPRN2 SUPT5H ABCD3 MTMR2 TMEM131L DLG1 C3 DLG4 GNAI1 GNAI2 CORO7 ALDH3A2 HECTD1 WWC1 KPNA1 DIP2B NAGK MTHFD1L ACAD9 DUSP6 NUP98 SMC2 PPP2R2A ARL10 MTOR ALYREF CCAR2 EIF3C SNTB1 ATP5F1B | 3.29e-15 | 974 | 275 | 37 | 28675297 |
| Pubmed | GPHN MYH9 MYCBP2 SIPA1L3 MPDZ ZNF318 TMEM132B LRIG2 UBA1 FAM120A PTPRN2 KCNJ4 MIOS DLG1 PLEKHA5 DLG4 GNAI1 NLGN2 BSN NIPBL HSPA9 KPNA1 DIP2B CLIP2 ZNF618 SH3KBP1 KSR2 SMC2 MTOR NT5C2 MACF1 ALYREF CCAR2 LIMCH1 WDFY3 EML1 | 1.31e-14 | 963 | 275 | 36 | 28671696 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 ATR MAT2A RAB11A SRP68 DBT ME2 DPM1 PHGDH PIK3R4 SLC25A3 UBA1 FAM120A SUPT5H SUPT6H ABCD3 BSN ALDH3A2 NIPBL HSPA9 DNHD1 DYNC2H1 MTHFD1L ACAD9 NUP98 AGPS SMC2 CBR1 TGM3 PPP2R2A ATP6V0D1 MTOR AIFM1 RNF20 DYNC1LI1 ACIN1 SLC7A5 ALYREF CCAR2 MPHOSPH8 EIF3C ATP5F1B | 2.12e-13 | 1425 | 275 | 42 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 MYCBP2 MAT2A SRP68 DPM1 PHGDH PIK3R4 SLC25A3 UBA1 FAM120A ABCD3 DDX23 PYGB PLEKHA5 GNAI2 CORO7 NIPBL SDC1 HSPA9 KPNA1 ARHGAP23 MTHFD1L NEK7 AGPS SMC2 CBR1 TGM3 NSUN5 SUGP2 AIFM1 RNF20 DYNC1LI1 ACIN1 MACF1 ALYREF CCAR2 AATF WDFY3 CDC27 ATP5F1B | 7.71e-13 | 1353 | 275 | 40 | 29467282 |
| Pubmed | GPHN MYH9 HTRA1 CFL2 SIPA1L3 SRP68 NCAM2 PHGDH PIK3R4 SLC25A3 UBA1 FAM120A ABCD3 MTMR2 MIOS PYGB DLG1 PLEKHA5 DLG4 GNAI1 BSN CORO7 HSPA9 ARHGAP23 CLIP2 SH3KBP1 MYO18A CBR1 PDHX MADD PPP2R2A PPP2R2C ATP6V0D1 SUGP2 PLXNA4 MACF1 LIMCH1 EIF3C CROCC CACNA2D3 ATP5F1B | 1.05e-12 | 1431 | 275 | 41 | 37142655 | |
| Pubmed | CYP2A6 RAB11B MYH9 ACACB CFL2 SIPA1L3 RAB11A ZNF318 CNPY2 DCC RYR2 ABCB4 DDX23 DLG1 GNAI1 GNAI2 BSN MLPH NIPBL HSPA9 PTBP3 CUX2 PTBP2 PCDHGA2 NUP98 MYO18A SMC2 PLXNA4 ACIN1 MACF1 SLC7A5 CCAR2 AATF MPHOSPH8 IFT122 LIMCH1 POLQ CDC27 BTNL9 PCDHGA8 ATP5F1B | 1.34e-12 | 1442 | 275 | 41 | 35575683 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RAB11B MYH9 HIP1 MAT2A SRP68 ME2 PHGDH SLC25A3 UBA1 AARS2 SUPT5H PYGB DLG1 GNAI1 GNAI2 HSPA9 ILVBL MTHFD1L DTYMK NUP98 MYO18A AGPS SMC2 CBR1 TGM3 PPP2R2A CRYZ ATP6V0D1 MTOR AIFM1 ACIN1 ARPIN SLC7A5 ALYREF AATF EIF3C CDC27 ATP5F1B | 1.89e-11 | 1367 | 275 | 38 | 32687490 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GPHN RAB11B MYH9 CMTR1 SRP68 RNF40 CNPY2 DBT ME2 DPM1 ME3 SLC25A3 FAP AARS2 FMC1 ABCD3 GNAI2 KIFC3 ALDH3A2 HSPA9 ILVBL HSD17B7 ARHGAP23 MTHFD1L ACAD9 OAS2 CCDC80 AGPS CR1 SLC4A2 LIG1 TGM3 AIFM1 MTIF2 RNF20 NT5C2 ADAMTS14 CFAP44 ATP5F1B | 2.70e-11 | 1451 | 275 | 39 | 30550785 |
| Pubmed | PPP2R2D MYCBP2 SIPA1L3 PAK4 SIX4 DBT ME1 CEMIP2 NSD3 UBA1 PTPRN2 SUPT5H CGN ABCD3 MTMR2 MIOS DLG1 ALDH3A2 KPNA1 DUSP6 NUP98 CEP192 MADD PPP2R2A AIFM1 DNAAF10 LRP6 CCAR2 AATF EIF3C RPA3 SNTB1 | 8.46e-11 | 1049 | 275 | 32 | 27880917 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | PPP2R2D MPDZ RNF40 TUBGCP4 F5 CFB WASH6P CCM2 FAM120A SUPT6H MIOS C3 DIP2B NPTX1 ARHGAP23 MADD WASH3P PPP2R2A MTIF2 DYNC1LI1 LIMCH1 | 2.78e-10 | 475 | 275 | 21 | 31040226 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 MAT2A CFL2 SIPA1L3 SRP68 DBT F5 DPM1 PHGDH NSD3 SLC25A3 UBA1 FAM120A CGN ABCD3 DLG1 PLEKHA5 C3 GNAI1 GNAI2 UHRF2 HSPA9 KPNA1 NUP98 MYO18A SMC2 TGM3 NSUN5 PPP2R2A ACIN1 SLC7A5 ALYREF AATF ATP5F1B | 4.88e-10 | 1257 | 275 | 34 | 36526897 |
| Pubmed | MYH9 MYCBP2 SRP68 ZNF318 ME2 FAM120A SUPT5H SUPT6H CGN DDX23 PYGB HECTD1 NIPBL HSPA9 MTHFD1L NUP98 TGM3 SUGP2 MTOR ACIN1 MACF1 ALYREF CCAR2 AATF | 5.98e-10 | 653 | 275 | 24 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RAB11B MYCBP2 INSR ZNF318 F5 PHGDH SLC25A3 UBA1 AARS2 SUPT5H SUPT6H CGN ABCD3 DDX23 GNAI2 NIPBL HSPA9 NUP98 AGPS SMC2 CBR1 SUGP2 AIFM1 ACIN1 MACF1 ALYREF CCAR2 AATF EIF3C ATP5F1B | 8.86e-10 | 1024 | 275 | 30 | 24711643 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | GPHN PHF20 PPP2R2D SIPA1L3 INSR STK38 TUBGCP4 PHGDH UBA1 FAM120A DDX23 GNAI1 GNAI2 KIFC3 ALDH3A2 NIPBL KPNA1 HSD17B7 SH3KBP1 NUP98 TSEN54 TACC2 CEP192 LCK PPP2R2A AIFM1 DYNC1LI1 ALYREF CCAR2 EIF3C CDC27 RPA3 | 9.22e-10 | 1155 | 275 | 32 | 20360068 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | CMTR1 LAMA1 RYR1 SLC25A3 UBA1 CGN ABCD3 BSN HSPA9 DNHD1 MYO18A AIFM1 POLQ ATP5F1B | 1.42e-09 | 208 | 275 | 14 | 33230847 |
| Pubmed | HIP1 HTRA1 SRP68 PHGDH PTPRN2 ABCD3 DLG1 DLG4 NLGN2 NPTX1 ARHGAP23 CLIP2 MTHFD1L MYO18A CLIP3 DYNC1LI1 MACF1 TNK2 SERAC1 | 2.03e-09 | 430 | 275 | 19 | 32581705 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH9 PPP2R2D MAT2A DPM1 PHGDH ARL6IP4 SLC25A3 UBA1 AARS2 PYGB C3 HSPA9 MYO18A CCDC80 CBR1 TGM3 PPP2R2A PPP2R2B MTOR AIFM1 CCAR2 LIMCH1 ATP5F1B | 2.60e-09 | 647 | 275 | 23 | 26618866 |
| Pubmed | ATR MPDZ TUBGCP4 DPM1 CEMIP2 PIK3R4 WASH6P FAM120A SUPT5H ABCD3 PYGB DLG1 PLEKHA5 ILVBL DIP2B ARHGAP23 SMC2 MADD SLC4A2 TGFBI MTIF2 RNF20 IFT122 | 2.84e-09 | 650 | 275 | 23 | 38777146 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 MYCBP2 SIPA1L3 INSR SAMD12 NCAM2 ME2 TMCO4 KLHL29 FAM120A PTPRN2 SUPT6H NLRC5 DLG1 KATNIP NLGN2 HECTD1 MLPH KPNA1 DIP2B PTBP2 WNT7B KSR2 CEP192 MSH5 PPP2R2A PPP2R2C SUGP2 GUCY1A1 NT5C2 MACF1 TNK2 IFT122 LIMCH1 CROCC PDZD2 | 2.87e-09 | 1489 | 275 | 36 | 28611215 |
| Pubmed | GPHN MYH9 CMTR1 SRP68 RNF40 DPM1 PHGDH SUPT5H SUPT6H DDX23 BSN HSPA9 PTBP2 ACAD9 AGPS LCK SMC2 AIFM1 SLC7A5 ALYREF CCAR2 EIF3C CDC27 | 3.10e-09 | 653 | 275 | 23 | 33742100 | |
| Pubmed | MYCBP2 MAT2A SIPA1L3 NCAM2 RNF40 BTBD1 DPM1 ME3 STAT6 PIK3R4 FAM120A SUPT5H HPS4 MTMR2 DLG1 DLG4 KIFC3 HECTD1 NIPBL HSPA9 KPNA1 NAGK CLIP2 REV3L CBR1 MADD MTIF2 LRP4 MACF1 IFT122 EIF3C WDFY3 ATP5F1B | 3.24e-09 | 1285 | 275 | 33 | 35914814 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATR PPP2R2D CFL2 PAK4 INSR STK38 ACVR1B ACVR2A MAP3K1 BLK PIK3R4 NEK1 HSPA9 ARHGAP23 NEK7 COL5A3 CEP192 LCK TGM3 PPP2R2A AIFM1 TNK2 AKAP11 EIF3C PRKG1 CDC27 SNTB1 | 4.98e-09 | 910 | 275 | 27 | 36736316 |
| Pubmed | TUBGCP4 ME2 SLC25A3 AARS2 SUPT5H SUPT6H ABCD3 DDX23 PYGB ALDH3A2 HSPA9 KPNA1 PTBP3 PTBP2 MTHFD1L ACAD9 SMC2 ATP6V0D1 RNF20 DYNC1LI1 CDC27 | 5.20e-09 | 560 | 275 | 21 | 35241646 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | RAB11B TRIT1 ACACB RAB11A DBT ME1 ME2 ABCA9 ME3 SLC25A3 CKMT2 AARS2 FMC1 DHODH ABCD3 ALDH3A2 D2HGDH HSPA9 SERHL2 MTHFD1L ACAD9 AGPS PDHX MLYCD MECR AIFM1 MTIF2 HAO2 ATP5F1B | 6.02e-09 | 1047 | 275 | 29 | 18614015 |
| Pubmed | CFL2 MPDZ RNF40 BTBD1 UBA1 PYGB GNAI1 GNAI2 HECTD1 HSPA9 CLIP2 DYNC2H1 ARRDC4 ASAP3 CRYZ MACF1 | 7.62e-09 | 322 | 275 | 16 | 26514267 | |
| Pubmed | KBTBD3 MYH9 NUP210L STK38 SRP68 RNF40 PHGDH SUPT6H ABCD3 DDX23 GNAI2 ILVBL WWC1 KPNA1 FAT4 DYNC2H1 MTHFD1L MYO18A NEK7 ADGB CLIP3 GRIP2 LIMCH1 EML1 | 9.84e-09 | 754 | 275 | 24 | 35906200 | |
| Pubmed | MAT2A RAB11A SRP68 PHGDH SLC25A3 UBA1 AARS2 SUPT6H ABCD3 ALDH3A2 HECTD1 HSPA9 PTBP2 NUP98 SMC2 SUGP2 MTOR AIFM1 DYNC1LI1 CCAR2 EIF3C ATP5F1B | 1.01e-08 | 638 | 275 | 22 | 33239621 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MYCBP2 SRP68 DBT DPM1 PHGDH MAP3K1 ARL6IP4 PIK3R4 FAM120A MIOS HECTD1 MYO18A TACC2 SMC2 PDHX NSUN5 CRYZ SUGP2 AIFM1 ACIN1 MACF1 ALYREF CCAR2 AATF | 1.12e-08 | 759 | 275 | 24 | 35915203 |
| Pubmed | HIP1 SIPA1L3 RAB11A MPDZ SRP68 ZNF318 SIX4 TMEM205 PHGDH NSD3 SLC25A3 SUPT6H ABCD3 MIOS DLG1 ALDH3A2 NIPBL SDC1 ILVBL KPNA1 MTHFD1L ACAD9 PCDHB7 NSUN5 CELSR1 ATP6V0D1 MACF1 SLC7A5 AATF MPHOSPH8 LIMCH1 EIF3C CROCC CDC27 ATP5F1B | 1.13e-08 | 1497 | 275 | 35 | 31527615 | |
| Pubmed | 1.22e-08 | 55 | 275 | 8 | 18448421 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH9 HNMT PHGDH RYR1 CEMIP2 SLC25A3 UBA1 FBP1 GNAI1 GNAI2 KIFC3 NIPBL SDC1 NAPSA DNHD1 CUX2 SLC5A10 NAGK DYNC2H1 SMC2 CR1 CBR1 VPS13D CRYZ ATP6V0D1 ALYREF CROCC ATP5F1B | 1.25e-08 | 1016 | 275 | 28 | 19056867 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPHN MYH9 MAT2A SRP68 UNC13D ME1 STAT6 UBA1 SUPT5H MTMR2 PYGB GNAI2 HECTD1 HSPA9 KPNA1 NAGK NUP98 DPP3 SMC2 LIG1 PPP2R2A CRYZ MTOR DNAAF10 RNF20 NT5C2 DYNC1LI1 MACF1 CCAR2 LIMCH1 EIF3C CROCC RPA3 ATP5F1B | 1.89e-08 | 1455 | 275 | 34 | 22863883 |
| Pubmed | MYH9 MAT2A SIPA1L3 INSR RAB11A SRP68 DBT TUBGCP4 ME1 DPM1 PHGDH ARL6IP4 SLC25A3 FAM120A CGN ABCD3 DLG1 GNAI1 GNAI2 HECTD1 HSPA9 WWC1 PTBP3 NUP98 SMC2 PPP2R2A AIFM1 ACIN1 ALYREF LIMCH1 ATP5F1B | 2.12e-08 | 1247 | 275 | 31 | 27684187 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | RAB11B TRIT1 ACACB RAB11A DBT ME1 ME2 ABCA9 ME3 SLC25A3 CKMT2 AARS2 FMC1 DHODH ABCD3 ALDH3A2 HSPA9 SERHL2 MTHFD1L ACAD9 AGPS PDHX MLYCD MECR MTIF2 HAO2 | 2.94e-08 | 926 | 275 | 26 | 20877624 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RAB11B MYH9 PPP2R2D MYCBP2 RAB11A ME1 TMEM205 PHGDH RYR1 DUOX1 FBP1 PYGB NAGK DYNC2H1 COL5A3 DPP3 AIFM1 RNF20 NT5C2 MACF1 ALYREF EML1 HYDIN ATP5F1B | 3.55e-08 | 807 | 275 | 24 | 30575818 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | MYH9 ATR PAK4 SRP68 TUBGCP4 PHGDH PIK3R4 DDX23 NIPBL KPNA1 PTBP3 PTBP2 DTYMK SMC2 LENG9 NSUN5 DYNC1LI1 ACIN1 MACF1 CDC27 | 5.11e-08 | 582 | 275 | 20 | 20467437 |
| Pubmed | MYH9 MAT2A PAK4 STK38 MPDZ SRP68 DPM1 PHGDH SLC25A3 UBA1 ABCD3 DLG1 PLEKHA5 ALDH3A2 HSPA9 SMC2 AIFM1 LRP6 MACF1 ARPIN CDC27 ATP5F1B | 6.32e-08 | 708 | 275 | 22 | 39231216 | |
| Pubmed | RAB11B MYH9 ACACB INSR RAB11A SRP68 ZNF318 ACVR1B RYR2 CEMIP2 LRIG2 ABCD3 DLG1 HSPA9 FAT4 NUP98 CEP192 AGPS LIG1 ARL10 SUGP2 SLC7A5 CCAR2 | 7.52e-08 | 777 | 275 | 23 | 35844135 | |
| Pubmed | MAT2A RAB11A SRP68 SLC25A3 UBA1 AARS2 CGN ABCD3 DDX23 GNAI1 DTYMK MYO18A CCDC80 AGPS CRYZ ATP6V0D1 AIFM1 DYNC1LI1 ACIN1 ALYREF CCAR2 EIF3C RPA3 | 9.23e-08 | 786 | 275 | 23 | 29128334 | |
| Pubmed | AARS2 PTPRN2 KATNIP CARNS1 HECTD1 MADD VPS13D LRP4 MACF1 PDZD2 | 9.39e-08 | 130 | 275 | 10 | 12421765 | |
| Pubmed | MYCBP2 PAK4 RAB11A MPDZ CNPY2 DBT ME2 CEMIP2 LRIG2 FAM120A SUPT6H ABCD3 TMEM131L DDX23 DLG1 PLEKHA5 ALDH3A2 HSPA9 DYNC2H1 MTHFD1L ACAD9 MYO18A CEP192 PDHX SLC4A2 AIFM1 MTIF2 MACF1 SLC7A5 AKAP11 IFT122 SNTB1 ATP5F1B | 1.04e-07 | 1487 | 275 | 33 | 33957083 | |
| Pubmed | GPHN MAT2A UBA1 PYGB DLG1 C3 DLG4 BSN CARNS1 NPTX1 NAGK CLIP2 SH3KBP1 MACF1 ALYREF | 1.11e-07 | 341 | 275 | 15 | 29791485 | |
| Pubmed | SIPA1L3 MPDZ SLC25A3 NEK1 FAM120A PLEKHA5 HECTD1 WWC1 CEP192 VPS13D MACF1 AKAP11 | 1.24e-07 | 209 | 275 | 12 | 36779422 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MYH9 MAT2A PHGDH UBA1 FAM120A SUPT5H C3 HECTD1 HSPA9 DIP2B NAGK MTHFD1L SMC2 EIF3C ATP5F1B | 1.25e-07 | 344 | 275 | 15 | 30333137 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | MYH9 DPM1 PHGDH SLC25A3 UBA1 ABCD3 ALDH3A2 HSPA9 NUP98 SMC2 PPP2R2A AIFM1 DYNC1LI1 CCAR2 ATP5F1B | 1.25e-07 | 344 | 275 | 15 | 36282215 |
| Pubmed | HSF1 transcriptional activity is modulated by IER5 and PP2A/B55. | 1.31e-07 | 7 | 275 | 4 | 25816751 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | GPHN MYH9 PPP2R2D MYCBP2 MPDZ SRP68 RNF40 BTBD1 DBT SUPT6H ABCD3 MIOS DDX23 DLG1 ALDH3A2 HECTD1 KPNA1 DYNC2H1 MTHFD1L ACAD9 NUP98 CEP192 DPP3 TGM3 EIF3C CDC27 | 1.46e-07 | 1005 | 275 | 26 | 19615732 |
| Pubmed | GPHN MAT2A PIK3R4 LRIG2 FAM120A SAT1 DLG4 KATNIP GNAI2 BSN PRMT7 WNT7B NUP98 TSEN54 TACC2 RAX CLIP3 NIM1K RNF20 NCOA1 LRP6 ACIN1 CCAR2 WDFY3 EML1 CROCC | 1.49e-07 | 1006 | 275 | 26 | 15226823 | |
| Pubmed | MYH9 MYCBP2 MAT2A SRP68 DBT PHGDH SLC25A3 UBA1 FAM120A ABCD3 DLG1 HSPA9 KPNA1 SMC2 PDHX AIFM1 DYNC1LI1 ACIN1 ALYREF EIF3C CDC27 RPA3 ATP5F1B | 1.54e-07 | 809 | 275 | 23 | 32129710 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH9 MYCBP2 STK38 SRP68 DBT PHGDH NSD3 SLC25A3 SUPT5H SUPT6H ABCD3 MIOS DDX23 NIPBL PTBP3 DIP2B NPTX1 PTBP2 ZNF618 MYO18A AGPS SUGP2 DYNC1LI1 ACIN1 MACF1 MPHOSPH8 EIF3C | 1.70e-07 | 1082 | 275 | 27 | 38697112 |
| Pubmed | MYH9 MYCBP2 RNF40 TUBGCP4 F5 DPM1 PIK3R4 SLC25A3 FAM120A ABCD3 PYGB PLEKHA5 GNAI2 CORO7 ILVBL DIP2B MTHFD1L MYO18A OAS2 AGPS SLC4A2 PLXNC1 MTOR DYNC1LI1 TNK2 SLC7A5 IFT122 ATP5F1B | 2.24e-07 | 1168 | 275 | 28 | 19946888 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GPHN ARL2BP PPP2R2D MYCBP2 PAK4 SRP68 TUBGCP4 NEK1 UBA1 SUPT5H CGN ABCD3 MIOS PLEKHA5 C3 KATNIP DYNC2H1 ACAD9 NEK7 SMC2 PPP2R2A MTOR DNAAF10 DYNC1LI1 ALYREF CCAR2 IFT122 PRKG2 CDC27 RPA3 | 2.55e-07 | 1321 | 275 | 30 | 27173435 |
| Pubmed | GPHN CMTR1 PAK4 STK38 SIX4 ABCD3 PLEKHA5 GNAI2 PRMT7 SMC2 LIG1 PPP2R2A SUGP2 DYNC1LI1 MACF1 ALYREF MPHOSPH8 | 2.74e-07 | 472 | 275 | 17 | 38943005 | |
| Pubmed | HTRA1 ZNF318 DBT DPM1 NSD3 ADH4 ARL6IP4 FCSK FAM120A SAT1 PCDH19 DLG4 ILVBL WWC1 KPNA1 ARHGAP23 ARRDC4 ZNF618 REV3L PDHX PPP2R2A SUGP2 MTIF2 LRP4 MACF1 WDFY3 CDC27 | 3.12e-07 | 1116 | 275 | 27 | 31753913 | |
| Pubmed | DPM1 SLC25A3 UBA1 FAM120A AARS2 PYGB HECTD1 KPNA1 PTBP3 HSD17B7 MTHFD1L ACAD9 NUP98 AGPS LIG1 AIFM1 EIF3C CDC27 | 3.20e-07 | 534 | 275 | 18 | 35032548 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 MAT2A RAB11A SRP68 RNF40 DPM1 PHGDH ARL6IP4 SLC25A3 UBA1 SUPT6H ABCD3 DDX23 HECTD1 NIPBL HSPA9 KPNA1 MTHFD1L TACC2 SMC2 CBR1 PPP2R2A AIFM1 DNAAF10 RNF20 MACF1 SLC7A5 ALYREF CCAR2 EIF3C ATP5F1B | 3.44e-07 | 1415 | 275 | 31 | 28515276 |
| Pubmed | 3.69e-07 | 36 | 275 | 6 | 22422068 | ||
| Pubmed | GPHN MYH9 ACACB MYCBP2 DBT PHGDH RYR2 UBA1 ABCD3 PYGB DLG1 DLG4 BSN HSPA9 SH3KBP1 MYO18A TACC2 PDHX MADD ATP6V0D1 MECR SUGP2 DYNC1LI1 MACF1 SLC7A5 EIF3C ATP5F1B | 4.63e-07 | 1139 | 275 | 27 | 36417873 | |
| Pubmed | 4.67e-07 | 9 | 275 | 4 | 19762425 | ||
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 4.70e-07 | 87 | 275 | 8 | 17148452 | |
| Pubmed | DBT RYR2 SLC25A3 CKMT2 UBA1 NOD1 PYGB ALDH3A2 HSPA9 MYO18A PDHX MECR AIFM1 ATP5F1B | 4.75e-07 | 331 | 275 | 14 | 29199018 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | DCC PHGDH MAP3K1 SUPT5H SUPT6H ABCD3 DDX23 ILVBL KPNA1 DNHD1 DYNC2H1 NUP98 TSEN54 DPP3 SMC2 TGM3 ATP6V0D1 MTOR ALYREF CDC27 | 4.80e-07 | 670 | 275 | 20 | 22990118 |
| Pubmed | 4.89e-07 | 3 | 275 | 3 | 9514514 | ||
| Pubmed | CMTR1 SIPA1L3 LRIG2 NEK1 FAM120A AARS2 CGN NLGN2 PRMT7 HECTD1 ARHGAP23 CLIP2 DYNC2H1 ZNF618 VPS13D DNAH17 MACF1 | 5.01e-07 | 493 | 275 | 17 | 15368895 | |
| Pubmed | TRIT1 DBT ME2 DPM1 AARS2 FMC1 GNAI2 HSPA9 ILVBL PTBP3 MTHFD1L ACAD9 PDHX AIFM1 MTIF2 ATP5F1B | 5.12e-07 | 438 | 275 | 16 | 32628020 | |
| Pubmed | MYH9 HTRA1 MAT2A CFL2 RAB11A PHGDH SLC25A3 UBA1 FAM120A PYGB GNAI2 ALDH3A2 HSPA9 DPP10 MTHFD1L WNT7B AGPS SMC2 ALYREF EIF3C CDC27 ATP5F1B | 5.38e-07 | 803 | 275 | 22 | 36517590 | |
| Pubmed | DCC KCNJ4 PCDH19 DLG1 DLG4 NLGN2 SH3KBP1 PDHX PPP2R2B PLXNC1 MACF1 | 5.53e-07 | 197 | 275 | 11 | 36604605 | |
| Pubmed | RAB11B MYH9 MAT2A CFL2 RAB11A STK38 SRP68 PHGDH BLK SLC25A3 UBA1 FAM120A KRT25 HSPA9 KPNA1 CEP192 LCK SMC2 TGM3 RNF20 DYNC1LI1 MACF1 ALYREF CCAR2 EIF3C POLQ ATP5F1B | 5.86e-07 | 1153 | 275 | 27 | 29845934 | |
| Pubmed | MYCBP2 RAB11A CEMIP2 FBP1 PYGB GNAI1 GNAI2 PRMT7 MLPH ZNF618 ADGB PPP2R2A ATP5F1B | 5.91e-07 | 288 | 275 | 13 | 38496616 | |
| Pubmed | MAT2A PHGDH SLC25A3 TMCO4 HSPA9 MTHFD1L DPP3 PDHX ACIN1 EIF3C ATP5F1B | 7.44e-07 | 203 | 275 | 11 | 35012549 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH9 ACACB MAT2A SRP68 DBT DPM1 ARL6IP4 SLC25A3 FAM120A ABCD3 DDX23 GNAI2 NIPBL HSPA9 ILVBL KPNA1 PTBP3 MTHFD1L NUP98 AGPS SMC2 LIG1 AIFM1 ACIN1 CCAR2 AATF CDC27 RPA3 ATP5F1B | 7.75e-07 | 1318 | 275 | 29 | 30463901 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | MAT2A MPDZ SRP68 DPM1 PHGDH SLC25A3 ALDH3A2 HECTD1 HSPA9 KPNA1 NUP98 AGPS SMC2 PPP2R2A AIFM1 DYNC1LI1 RPA3 ATP5F1B | 8.40e-07 | 571 | 275 | 18 | 37167062 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIP1 MYCBP2 SIPA1L3 RNF40 ST14 RYR1 NSD3 NLRC5 PYGB NLGN2 KIFC3 HECTD1 D2HGDH MTHFD1L WNT7B KSR2 CEP192 REV3L MADD CELSR1 SUGP2 MTOR LRP4 TNK2 SLC7A5 WDFY3 | 8.77e-07 | 1105 | 275 | 26 | 35748872 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | CMTR1 ACACB ZNF318 PHGDH UBA1 SUPT5H CORO7 HSPA9 TGM3 PPP2R2A PPP2R2C SUGP2 CCAR2 ATP5F1B | 1.16e-06 | 357 | 275 | 14 | 37059091 |
| Pubmed | MYH9 PPP2R2D MAT2A CFL2 SRP68 ZNF318 ME2 DPM1 PHGDH MAP3K1 SLC25A3 PYGB HSPA9 KPNA1 AGPS TGM3 PPP2R2A PPP2R2B HMCN1 MACF1 EIF3C ATP5F1B | 1.22e-06 | 844 | 275 | 22 | 25963833 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MYH9 HTRA1 ATR MYCBP2 LAMA1 CNPY2 CEMIP2 LRIG2 FAP UBA1 TMEM131L PLEKHA5 GNAI2 ALDH3A2 HECTD1 FAT4 NPTX1 MADD SLC4A2 TGFBI PPP2R2A CELSR1 LRP4 LRP6 SLC7A5 CHSY3 ATP5F1B | 1.27e-06 | 1201 | 275 | 27 | 35696571 |
| Pubmed | MYH9 UBA1 AARS2 CGN PLEKHA5 CORO7 NIPBL HSPA9 NUP98 MLYCD RNF20 DYNC1LI1 ACIN1 MACF1 | 1.28e-06 | 360 | 275 | 14 | 33111431 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RAB11B MYH9 MAT2A CFL2 RAB11A RNF40 SUPT6H DDX23 NIPBL HSPA9 KPNA1 PTBP3 PTBP2 SMC2 NSUN5 PPP2R2A RNF20 DYNC1LI1 MACF1 CCAR2 EIF3C ATP5F1B | 1.30e-06 | 847 | 275 | 22 | 35235311 |
| Pubmed | 1.39e-06 | 135 | 275 | 9 | 31405213 | ||
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | TRIT1 DBT ME2 ME3 SLC25A3 CKMT2 AARS2 FMC1 DHODH KIFC3 D2HGDH HSPA9 HSD17B7 MTHFD1L ACAD9 DTYMK PDHX MLYCD VPS13D CRYZ ARL10 MECR AIFM1 MTIF2 SERAC1 ATP5F1B | 1.46e-06 | 1136 | 275 | 26 | 34800366 |
| Pubmed | MYH9 HIP1 CFL2 SIPA1L3 F5 ARL6IP4 SUPT5H DDX23 DLG1 GNAI2 KPNA1 NUP98 MYO18A AIFM1 ACIN1 MACF1 ALYREF EIF3C RPA3 | 1.59e-06 | 660 | 275 | 19 | 32780723 | |
| Pubmed | RAB11B CFL2 RAB11A TMEM205 ME2 SLC25A3 GLMP UBA1 AARS2 GNAI2 HSPA9 HSD17B7 AGPS PDHX CRYZ ATP6V0D1 GIMAP8 AIFM1 PLXNA4 LRP4 ATP5F1B PDZD2 | 1.63e-06 | 859 | 275 | 22 | 31536960 | |
| Pubmed | RAB11B HIP1 RYR1 PIK3R4 GLMP BMX SUPT5H CGN MTMR2 C3 DLG4 CX3CL1 SLC5A10 PTBP2 SH3GL3 SH3KBP1 ACTRT2 REV3L PPP2R2B MTOR DNAAF10 MTIF2 NT5C2 LRP6 TNF POLQ CDC27 HYDIN | 1.65e-06 | 1293 | 275 | 28 | 15342556 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYH9 PHF20 ATR RNF40 ZNF318 SIX4 DPM1 NSD3 ARL6IP4 SLC25A3 SUPT5H SUPT6H DDX23 NIPBL HSPA9 ILVBL NAPSA NUP98 SMC2 RNF20 ACIN1 SLC7A5 ALYREF AATF MPHOSPH8 CDC27 RPA3 ATP5F1B | 1.68e-06 | 1294 | 275 | 28 | 30804502 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN MYCBP2 SIPA1L3 PAK4 MPDZ NSD3 PIK3R4 NEK1 BMX CGN PLEKHA5 HECTD1 DIP2B MAP3K14 CEP192 LCK MADD VPS13D MTOR MACF1 AKAP11 LIMCH1 | 1.69e-06 | 861 | 275 | 22 | 36931259 |
| Pubmed | MYH9 MYCBP2 MAT2A SRP68 CNPY2 PHGDH NSD3 SLC25A3 UBA1 FAM120A C3 GNAI2 ALDH3A2 HECTD1 NIPBL HSPA9 ILVBL MTHFD1L ACAD9 AGPS NSUN5 ATP6V0D1 AIFM1 NT5C2 MACF1 CCAR2 CROCC CDC27 | 1.75e-06 | 1297 | 275 | 28 | 33545068 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN MYH9 ACACB PAK4 SRP68 ZNF318 ME2 PHGDH SLC25A3 NEK1 UBA1 ABCD3 PRMT7 ALDH3A2 NIPBL HSPA9 NUP98 TACC2 SUGP2 ACIN1 MACF1 EIF3C ATP5F1B | 1.81e-06 | 934 | 275 | 23 | 33916271 |
| Pubmed | MYH9 STK38 RNF40 PHGDH SLC25A3 HSPA9 SMC2 TGM3 AIFM1 NT5C2 CCAR2 EIF3C ATP5F1B | 1.91e-06 | 320 | 275 | 13 | 28685749 | |
| Pubmed | Membrane protein Crry maintains homeostasis of the complement system. | 1.94e-06 | 4 | 275 | 3 | 18684964 | |
| Pubmed | 1.94e-06 | 4 | 275 | 3 | 24441044 | ||
| Pubmed | GPHN MYCBP2 MPDZ SRP68 ZNF318 PHGDH NSD3 SLC25A3 NEK1 UBA1 CGN DLG1 PLEKHA5 SMC2 SUGP2 ACIN1 ARPIN | 2.17e-06 | 549 | 275 | 17 | 38280479 | |
| Pubmed | STK38 KIFC3 HSPA9 DNHD1 DYNC2H1 ZNF618 MYO18A EIF3C CROCC CFAP44 | 2.68e-06 | 187 | 275 | 10 | 26460568 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MYCBP2 RNF40 ZNF318 SUPT5H SUPT6H ABCD3 MIOS HECTD1 KPNA1 NUP98 AGPS AIFM1 RNF20 AATF CDC27 | 2.73e-06 | 440 | 275 | 15 | 34244565 |
| Pubmed | MYH9 MAT2A STK38 PHGDH AARS2 DDX23 HSPA9 SMC2 PPP2R2A RNF20 ALYREF CCAR2 EIF3C CDC27 ATP5F1B | 2.80e-06 | 441 | 275 | 15 | 31239290 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | GPHN MYH9 CMTR1 MYCBP2 ZNF318 PLEKHA5 HECTD1 KPNA1 NPTX1 ACAD9 NUP98 MYO18A AGPS PPP2R2A SUGP2 MTOR MTIF2 AATF LIMCH1 EIF3C | 2.91e-06 | 754 | 275 | 20 | 33060197 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MYCBP2 MAT2A RNF40 DPM1 PHGDH PIK3R4 SLC25A3 UBA1 ABCD3 DDX23 PYGB ALDH3A2 HECTD1 HSPA9 ILVBL KPNA1 MTHFD1L SMC2 NSUN5 PPP2R2A AIFM1 DYNC1LI1 SLC7A5 CCAR2 EIF3C CDC27 ATP5F1B | 2.98e-06 | 1257 | 275 | 27 | 37317656 |
| Pubmed | PPP2R2D MAT2A MPDZ SRP68 DBT DPM1 PHGDH SLC25A3 UBA1 FAM120A SUPT5H ABCD3 ALDH3A2 HECTD1 HSPA9 KPNA1 NAGK MTHFD1L ACAD9 PPP2R2A AIFM1 DNAAF10 SLC7A5 ALYREF CCAR2 EIF3C CDC27 ATP5F1B | 3.04e-06 | 1335 | 275 | 28 | 29229926 | |
| Pubmed | AARS2 ABCD3 KPNA1 DIP2B MTHFD1L AGPS SMC2 PPP2R2A DYNC1LI1 SLC7A5 CCAR2 | 3.36e-06 | 237 | 275 | 11 | 29564676 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | MAT2A DBT DPM1 PHGDH ARL6IP4 SLC25A3 UBA1 FAM120A CORO7 HSPA9 PTBP3 DIP2B PTBP2 SMC2 PDHX ALYREF MPHOSPH8 EIF3C ATP5F1B | 3.81e-06 | 701 | 275 | 19 | 30196744 |
| Pubmed | HIP1 CFL2 TUBGCP4 DPM1 PHGDH SLC25A3 FAM120A AARS2 ABCD3 DDX23 ALDH3A2 ILVBL MTHFD1L ACAD9 MAP3K14 SMC2 PPP2R2A ATP6V0D1 MTOR AIFM1 LRP4 DYNC1LI1 SLC7A5 ALYREF CCAR2 LIMCH1 EIF3C RPA3 ATP5F1B | 4.40e-06 | 1440 | 275 | 29 | 30833792 | |
| Interaction | PPIA interactions | GPHN MYH9 CMTR1 PAK4 STK38 SRP68 BTBD1 SIX4 TMEM132B IFIH1 FBP1 SUPT5H ABCD3 PLEKHA5 DLG4 GNAI2 PRMT7 DYNC2H1 HEATR5A SMC2 SLC4A2 LIG1 PPP2R2A ARL10 SUGP2 AIFM1 RNF20 DYNC1LI1 MACF1 ALYREF MPHOSPH8 RPA3 | 4.08e-07 | 888 | 271 | 32 | int:PPIA |
| Interaction | KCNA3 interactions | MYH9 CMTR1 MAT2A PAK4 LAMA1 STK38 MPDZ SRP68 DPM1 PHGDH RYR1 SLC25A3 UBA1 CGN ABCD3 DLG1 PLEKHA5 DLG4 BSN ALDH3A2 HSPA9 DNHD1 MYO18A SMC2 AIFM1 LRP6 MACF1 ARPIN POLQ CDC27 ATP5F1B | 8.18e-07 | 871 | 271 | 31 | int:KCNA3 |
| Interaction | ATG16L1 interactions | HIP1 ACACB MYCBP2 MAT2A SIPA1L3 RAB11A UNC13D DBT DPM1 PHGDH RYR2 ARL6IP4 SLC25A3 UBA1 NOD1 FAM120A HPS4 C3 KATNIP CORO7 HSPA9 DENND5B PTBP3 DIP2B PTBP2 CEP192 AGPS SMC2 PDHX PPP2R2A NT5C2 TNK2 ALYREF MPHOSPH8 EIF3C WDFY3 ATP5F1B | 9.56e-07 | 1161 | 271 | 37 | int:ATG16L1 |
| Interaction | LIMCH1 interactions | 9.79e-07 | 100 | 271 | 10 | int:LIMCH1 | |
| Interaction | YWHAZ interactions | RAB11B ARL2BP MYH9 PPP2R2D MYCBP2 SIPA1L3 PAK4 STK38 NCAM2 MAP3K1 NEK1 UBA1 CGN PLEKHA5 C3 DLG4 KATNIP ALDH3A2 HECTD1 HSPA9 CLIP2 KSR2 MYO18A TACC2 CEP192 LCK SMC2 CBR1 MADD VPS13D MTOR DYNC1LI1 MACF1 TNK2 CCAR2 AKAP11 WDFY3 RPA3 ATP5F1B | 2.95e-06 | 1319 | 271 | 39 | int:YWHAZ |
| Interaction | KCTD13 interactions | GPHN MYH9 HTRA1 CFL2 SIPA1L3 SRP68 NCAM2 PHGDH PIK3R4 SLC25A3 UBA1 FAM120A ABCD3 MTMR2 MIOS PYGB DLG1 PLEKHA5 DLG4 GNAI1 BSN CORO7 HSPA9 ARHGAP23 CLIP2 SH3KBP1 MYO18A CBR1 PDHX MADD PPP2R2A PPP2R2C ATP6V0D1 SUGP2 PLXNA4 MACF1 LIMCH1 CROCC CACNA2D3 ATP5F1B | 4.48e-06 | 1394 | 271 | 40 | int:KCTD13 |
| Interaction | SLC6A4 interactions | HIP1 HTRA1 SRP68 PHGDH PTPRN2 ABCD3 DLG1 DLG4 NLGN2 NPTX1 ARHGAP23 CLIP2 MTHFD1L MYO18A CLIP3 DYNC1LI1 MACF1 TNK2 SERAC1 | 7.98e-06 | 437 | 271 | 19 | int:SLC6A4 |
| Interaction | BIRC3 interactions | MYH9 ATR MAT2A RAB11A SRP68 DBT ME2 DPM1 PHGDH SLC25A3 UBA1 SUPT5H SUPT6H ABCD3 ALDH3A2 HSPA9 DNHD1 DYNC2H1 MTHFD1L ACAD9 NUP98 AGPS SMC2 CBR1 TGM3 PPP2R2A ATP6V0D1 MTOR AIFM1 RNF20 DYNC1LI1 ACIN1 SLC7A5 ALYREF CCAR2 MPHOSPH8 TNF ATP5F1B | 9.45e-06 | 1334 | 271 | 38 | int:BIRC3 |
| Interaction | C9orf78 interactions | BTBD1 TUBGCP4 ME2 SLC25A3 AARS2 SUPT5H SUPT6H ABCD3 DDX23 PYGB ALDH3A2 HSPA9 KPNA1 PTBP3 PTBP2 MTHFD1L ACAD9 SMC2 ATP6V0D1 RNF20 DYNC1LI1 CDC27 RPA3 | 1.20e-05 | 620 | 271 | 23 | int:C9orf78 |
| Interaction | NGB interactions | KBTBD3 MYH9 UBA1 FAM120A GNAI1 GNAI2 HSPA9 KSR2 PLXNA4 ALYREF ATP5F1B | 1.34e-05 | 163 | 271 | 11 | int:NGB |
| Interaction | ATP5MG interactions | MYH9 RAB11A TUBGCP4 BLK ALDH3A2 HSPA9 ILVBL ACAD9 AIFM1 MTIF2 RPA3 ATP5F1B | 1.39e-05 | 195 | 271 | 12 | int:ATP5MG |
| Interaction | XPNPEP1 interactions | 1.79e-05 | 110 | 271 | 9 | int:XPNPEP1 | |
| Interaction | KCNJ2 interactions | 1.95e-05 | 42 | 271 | 6 | int:KCNJ2 | |
| Interaction | CDC73 interactions | MYH9 ATR RNF40 PHGDH BMX UBA1 SUPT5H DDX23 UHRF2 HECTD1 HSPA9 WWC1 NUP98 RNF20 SLC7A5 RPA3 ATP5F1B | 2.05e-05 | 386 | 271 | 17 | int:CDC73 |
| Interaction | IER5 interactions | 2.08e-05 | 13 | 271 | 4 | int:IER5 | |
| Interaction | DHRS4L2 interactions | 2.08e-05 | 13 | 271 | 4 | int:DHRS4L2 | |
| Interaction | CAPZA2 interactions | MYH9 CFL2 SIPA1L3 WASH6P FBP1 CGN DLG4 GNAI2 ALDH3A2 SH3KBP1 MYO18A SMC2 TGM3 WASH3P DYNC1LI1 MACF1 LIMCH1 RPA3 | 2.30e-05 | 430 | 271 | 18 | int:CAPZA2 |
| Interaction | EED interactions | RAB11B MYH9 HIP1 ACACB MYCBP2 LAMA1 STK38 SRP68 DBT PHGDH SLC25A3 UBA1 SUPT5H SUPT6H CGN ABCD3 GNAI2 UHRF2 HECTD1 NIPBL HSPA9 KPNA1 MTHFD1L DTYMK NUP98 MYO18A SMC2 CBR1 LIG1 NSUN5 PPP2R2A ATP6V0D1 ACIN1 MACF1 ALYREF CCAR2 LIMCH1 CROCC ATP5F1B | 2.43e-05 | 1445 | 271 | 39 | int:EED |
| Interaction | SIRT7 interactions | MYH9 ATR MYCBP2 SRP68 ZNF318 ME2 FAM120A SUPT5H SUPT6H CGN DDX23 PYGB HECTD1 NIPBL HSPA9 MTHFD1L NUP98 TGM3 SUGP2 MTOR ACIN1 MACF1 ALYREF CCAR2 AATF | 2.65e-05 | 744 | 271 | 25 | int:SIRT7 |
| Interaction | RHOB interactions | HIP1 SIPA1L3 PAK4 INSR RAB11A ACVR1B PHGDH CEMIP2 SLC25A3 CCM2 UBA1 PCDH19 DLG1 PLEKHA5 GNAI2 HSPA9 KPNA1 DIP2B FAT4 MYO18A PDHX LRP4 LRP6 MACF1 SLC7A5 CDC27 SNTB1 | 2.71e-05 | 840 | 271 | 27 | int:RHOB |
| Interaction | SLX4 interactions | CMTR1 ACACB ZNF318 PHGDH UBA1 SUPT5H SUPT6H CORO7 NIPBL HSPA9 KPNA1 REV3L TGM3 PPP2R2A PPP2R2C SUGP2 CCAR2 AATF POLQ RPA3 ATP5F1B | 3.38e-05 | 572 | 271 | 21 | int:SLX4 |
| Interaction | CAPZB interactions | MYH9 HIP1 CFL2 SIPA1L3 RAB11A SRP68 RNF40 ME2 PIK3R4 CKMT2 WASH6P FBP1 FAM120A NIPBL HSPA9 PTBP3 MTHFD1L SH3KBP1 MYO18A TACC2 SMC2 WASH3P PPP2R2B RNF20 DYNC1LI1 ALYREF EIF3C CROCC CDC27 RPA3 ATP5F1B | 3.40e-05 | 1049 | 271 | 31 | int:CAPZB |
| Interaction | FNDC5 interactions | GPHN RAB11B MYH9 HTRA1 CMTR1 SRP68 RNF40 CNPY2 DBT ME2 DPM1 ME3 SLC25A3 FAP AARS2 FMC1 ABCD3 C3 GNAI2 KIFC3 HSPA9 ILVBL HSD17B7 ARHGAP23 MTHFD1L ACAD9 CCDC80 AGPS CBR1 SLC4A2 LIG1 TGM3 AIFM1 MTIF2 RNF20 NT5C2 ADAMTS14 CFAP44 ATP5F1B | 3.55e-05 | 1470 | 271 | 39 | int:FNDC5 |
| Interaction | DLST interactions | PAK4 SRP68 DBT UBA1 AARS2 CGN DDX23 HECTD1 HSPA9 ACAD9 MYO18A CCDC80 CRYZ AIFM1 MTIF2 DYNC1LI1 ACIN1 RPA3 ATP5F1B | 3.89e-05 | 490 | 271 | 19 | int:DLST |
| Interaction | SNX4 interactions | 3.90e-05 | 69 | 271 | 7 | int:SNX4 | |
| Interaction | CMTR1 interactions | CMTR1 RNF40 PHGDH FAM120A SUPT5H DDX23 PTBP3 RNF20 NT5C2 ALYREF CCAR2 RPA3 | 4.17e-05 | 218 | 271 | 12 | int:CMTR1 |
| Interaction | MAP1B interactions | MYH9 CMTR1 MAT2A STK38 PHGDH SLC25A3 CKMT2 FAM120A DDX23 HECTD1 ARRDC4 AIFM1 NT5C2 TNK2 SLC7A5 CCAR2 TNF EIF3C RPA3 ATP5F1B | 4.50e-05 | 539 | 271 | 20 | int:MAP1B |
| Interaction | PHB2 interactions | RAB11B ATR RAB11A PHGDH BLK SLC25A3 FAP FBP1 AARS2 DLG4 HECTD1 HSPA9 KPNA1 ACAD9 AGPS VPS13D AIFM1 AATF RPA3 ATP5F1B | 4.62e-05 | 540 | 271 | 20 | int:PHB2 |
| Interaction | WNT3A interactions | 4.82e-05 | 49 | 271 | 6 | int:WNT3A | |
| Interaction | GSK3A interactions | ACACB SIPA1L3 MPDZ SLC25A3 NEK1 FAM120A PLEKHA5 HECTD1 WWC1 PTBP2 CEP192 VPS13D SUGP2 LRP6 ACIN1 MACF1 AKAP11 RPA3 | 6.18e-05 | 464 | 271 | 18 | int:GSK3A |
| Interaction | ECT2 interactions | MYH9 MYCBP2 CFL2 SRP68 PHGDH ARL6IP4 FAP FAM120A ABCD3 DDX23 GNAI1 GNAI2 KIFC3 ALDH3A2 HECTD1 ILVBL NUP98 MYO18A AGPS MADD ATP6V0D1 AIFM1 ACIN1 MACF1 ALYREF AATF PDZD2 | 6.87e-05 | 887 | 271 | 27 | int:ECT2 |
| Interaction | RAD21 interactions | EVX1 CCM2 UBA1 FAM120A C3 HECTD1 NIPBL KPNA1 DIP2B SMC2 CBR1 ALYREF CCAR2 EIF3C RPA3 PDZD2 | 6.93e-05 | 384 | 271 | 16 | int:RAD21 |
| Interaction | DVL2 interactions | HIP1 HTRA1 MAP3K1 ARL6IP4 PIK3R4 ABCD3 PLEKHA5 UHRF2 HSPA9 NAGK SH3KBP1 AGPS REV3L SMC2 PPP2R2A HMCN1 AIFM1 MACF1 CCAR2 RPA3 | 7.08e-05 | 557 | 271 | 20 | int:DVL2 |
| Interaction | CFD interactions | GPHN RAB11B MYH9 CMTR1 SRP68 RNF40 CNPY2 DBT ME2 DPM1 ME3 SLC25A3 FAP AARS2 FMC1 ABCD3 GNAI2 KIFC3 HSPA9 ILVBL HSD17B7 ARHGAP23 MTHFD1L ACAD9 CCDC80 AGPS SLC4A2 LIG1 TGM3 AIFM1 MTIF2 RNF20 NT5C2 ADAMTS14 CFAP44 ATP5F1B | 7.67e-05 | 1360 | 271 | 36 | int:CFD |
| Interaction | CCDC8 interactions | MYCBP2 ZNF318 F5 PHGDH SLC25A3 UBA1 AARS2 PTPRN2 CGN GNAI2 HECTD1 NIPBL HSPA9 AGPS LCK SMC2 SUGP2 AIFM1 MACF1 CCAR2 EIF3C ATP5F1B | 8.40e-05 | 656 | 271 | 22 | int:CCDC8 |
| Interaction | RUFY1 interactions | MYH9 RAB11A RNF40 DPM1 PHGDH SLC25A3 BMX UBA1 ABCD3 ALDH3A2 HSPA9 NUP98 SMC2 PPP2R2A AIFM1 DYNC1LI1 CCAR2 ATP5F1B | 8.55e-05 | 476 | 271 | 18 | int:RUFY1 |
| Interaction | FLT4 interactions | DPM1 SLC25A3 ALDH3A2 CX3CL1 ILVBL MTHFD1L SH3KBP1 SMC2 DNAAF10 DYNC1LI1 TNF CROCC SNTB1 | 8.59e-05 | 272 | 271 | 13 | int:FLT4 |
| Interaction | CFTR interactions | MYH9 HIP1 PPP2R2D MAT2A RAB11A SRP68 HNMT DPM1 PHGDH RYR2 ARL6IP4 SLC25A3 UBA1 NOD1 FAM120A AARS2 CGN PYGB DLG1 C3 GNAI2 HSPA9 MYO18A CCDC80 CBR1 PDHX TGFBI TGM3 PPP2R2A PPP2R2B MTOR AIFM1 MACF1 CCAR2 SERAC1 LIMCH1 PRKG1 ATP5F1B | 9.03e-05 | 1480 | 271 | 38 | int:CFTR |
| Interaction | RNGTT interactions | 1.01e-04 | 137 | 271 | 9 | int:RNGTT | |
| Interaction | SERTAD4 interactions | 1.06e-04 | 19 | 271 | 4 | int:SERTAD4 | |
| Interaction | DSCAM interactions | MAT2A BTBD1 SUPT5H DLG1 DLG4 KIFC3 MACF1 IFT122 EIF3C ATP5F1B | 1.11e-04 | 171 | 271 | 10 | int:DSCAM |
| Interaction | NCBP2 interactions | 1.26e-04 | 141 | 271 | 9 | int:NCBP2 | |
| Interaction | IER2 interactions | 1.30e-04 | 37 | 271 | 5 | int:IER2 | |
| Interaction | KIF13B interactions | 1.33e-04 | 142 | 271 | 9 | int:KIF13B | |
| Interaction | HSPA9 interactions | MYH9 MYCBP2 MAT2A ACVR1B TUBGCP4 PHGDH BLK FBP1 AARS2 SUPT6H DDX23 HSPA9 ACAD9 DUSP6 SH3KBP1 TACC2 LCK AIFM1 MTIF2 TNK2 ALYREF RPA3 ATP5F1B | 1.38e-04 | 727 | 271 | 23 | int:HSPA9 |
| Interaction | EP300 interactions | GPHN MYH9 CMTR1 ATR SRP68 RNF40 DPM1 PHGDH STAT6 SUPT5H SUPT6H ABCD3 DDX23 C3 BSN HECTD1 SDC1 HSPA9 PTBP2 ACAD9 NUP98 TACC2 AGPS LCK SMC2 PDHX MTOR AIFM1 NCOA1 TNK2 SLC7A5 ALYREF CCAR2 EIF3C CDC27 RPA3 | 1.39e-04 | 1401 | 271 | 36 | int:EP300 |
| Interaction | TOMM22 interactions | DPM1 SLC25A3 ABCD3 GNAI2 ALDH3A2 LCK VPS13D ATP6V0D1 ARL10 AIFM1 PLXNA4 DYNC1LI1 SLC7A5 RPA3 ATP5F1B | 1.48e-04 | 368 | 271 | 15 | int:TOMM22 |
| Interaction | CDK9 interactions | MYH9 ATR SIPA1L3 SRP68 RNF40 PHGDH SLC25A3 SUPT5H ABCD3 HSPA9 MTHFD1L DTYMK NUP98 MYO18A SMC2 AIFM1 RNF20 ACIN1 ALYREF CCAR2 RPA3 ATP5F1B | 1.56e-04 | 685 | 271 | 22 | int:CDK9 |
| Interaction | G6PD interactions | MAT2A PAK4 RAB11A UNC13D UBA1 MTMR2 DLG4 HSPA9 SH3GL3 TNF RPA3 | 1.59e-04 | 214 | 271 | 11 | int:G6PD |
| Interaction | CRHR1 interactions | 1.60e-04 | 21 | 271 | 4 | int:CRHR1 | |
| Interaction | GAN interactions | STK38 UBA1 KIFC3 HSPA9 DNHD1 DYNC2H1 ZNF618 MYO18A EIF3C CROCC CFAP44 RPA3 | 1.72e-04 | 253 | 271 | 12 | int:GAN |
| Interaction | ETFB interactions | DBT PHGDH AARS2 HSPA9 ACAD9 CRYZ MECR AIFM1 MTIF2 AKAP11 RPA3 ATP5F1B | 1.72e-04 | 253 | 271 | 12 | int:ETFB |
| Interaction | DSCR9 interactions | 1.72e-04 | 147 | 271 | 9 | int:DSCR9 | |
| Interaction | AR interactions | MYCBP2 RNF40 ZNF318 DCC ME1 PHGDH BLK CGN ABCD3 DDX23 GNAI1 NIPBL HSPA9 MYO18A LCK PPP2R2A SUGP2 MYLIP RNF20 NCOA1 ACIN1 TNK2 CCAR2 AATF LIMCH1 PRKG1 CDC27 ATP5F1B | 1.80e-04 | 992 | 271 | 28 | int:AR |
| Interaction | MAT2A interactions | MAT1A MAT2A BMX UBA1 AARS2 HSPA9 ARHGAP23 DUSP6 SH3GL3 LCK RPA3 | 1.87e-04 | 218 | 271 | 11 | int:MAT2A |
| Interaction | NT5DC2 interactions | 1.97e-04 | 118 | 271 | 8 | int:NT5DC2 | |
| Interaction | DCAF6 interactions | ACACB MYCBP2 MAT1A ARL6IP4 SUPT5H DLG4 KPNA1 DUSP6 NSUN5 PPP2R2A WDFY3 | 2.11e-04 | 221 | 271 | 11 | int:DCAF6 |
| Interaction | ME2 interactions | 2.12e-04 | 90 | 271 | 7 | int:ME2 | |
| Interaction | GABRA1 interactions | 2.22e-04 | 152 | 271 | 9 | int:GABRA1 | |
| Interaction | HUWE1 interactions | GPHN MYH9 ACACB MYCBP2 MAT2A SRP68 DBT DPM1 PHGDH SLC25A3 FAP UBA1 DLG1 DLG4 ALDH3A2 HECTD1 HSPA9 KPNA1 ARRDC4 NUP98 AGPS SMC2 PPP2R2A AIFM1 NT5C2 DYNC1LI1 MACF1 LIMCH1 RPA3 ATP5F1B | 2.22e-04 | 1110 | 271 | 30 | int:HUWE1 |
| Interaction | STIP1 interactions | MAT2A RAB11A SRP68 ME1 PHGDH PIK3R4 SLC25A3 UBA1 AARS2 SUPT6H ABCD3 ALDH3A2 HECTD1 HSPA9 PTBP2 NUP98 LCK SMC2 ADGB SUGP2 MTOR AIFM1 DYNC1LI1 CCAR2 EIF3C RPA3 HAO2 ATP5F1B | 2.26e-04 | 1006 | 271 | 28 | int:STIP1 |
| Interaction | PLEC interactions | GPHN MYH9 HIP1 ATR STAT6 PLEKHA5 GNAI2 ARHGAP23 MYO18A SMC2 PPP2R2B AIFM1 MACF1 CCAR2 TNF RPA3 | 2.53e-04 | 430 | 271 | 16 | int:PLEC |
| Interaction | EXD2 interactions | RAB11B RAB11A DBT ME2 AARS2 ABCD3 ALDH3A2 MTHFD1L ACAD9 VPS13D ARL10 AIFM1 MTIF2 ALYREF ATP5F1B | 2.62e-04 | 388 | 271 | 15 | int:EXD2 |
| Interaction | HDAC5 interactions | MYH9 PPP2R2D TUBGCP4 F5 PHGDH CFB SLC25A3 UBA1 SUPT6H CGN C3 HSPA9 PPP2R2A CCAR2 EIF3C ATP5F1B | 2.66e-04 | 432 | 271 | 16 | int:HDAC5 |
| Interaction | TERF1 interactions | MYH9 PAK4 RNF40 HNMT RYR2 FBP1 SUPT5H DDX23 HECTD1 NAGK SH3GL3 NEK7 DPP3 MTOR | 2.73e-04 | 347 | 271 | 14 | int:TERF1 |
| Interaction | DLD interactions | MAT2A CFL2 RAB11A DBT PHGDH UBA1 AARS2 FMC1 DDX23 HECTD1 DTYMK DPP3 PDHX AIFM1 DYNC1LI1 ACIN1 EIF3C RPA3 | 2.93e-04 | 526 | 271 | 18 | int:DLD |
| Interaction | SHMT2 interactions | ARL2BP MPDZ ME2 NOD1 AARS2 SUPT5H HSPA9 DNHD1 FAT4 ACAD9 MYO18A NEK7 NT5C3B MADD CRYZ MTOR AIFM1 MTIF2 MACF1 WDFY3 RPA3 | 3.11e-04 | 671 | 271 | 21 | int:SHMT2 |
| Interaction | IFNG interactions | 3.24e-04 | 25 | 271 | 4 | int:IFNG | |
| Interaction | RHOF interactions | RAB11B HIP1 ATR CFL2 SIPA1L3 PAK4 MPDZ DPM1 CEMIP2 CCM2 DLG1 PLEKHA5 ALDH3A2 KPNA1 FAT4 HEATR5A SLC4A2 MTOR DYNC1LI1 MACF1 SLC7A5 | 3.24e-04 | 673 | 271 | 21 | int:RHOF |
| Interaction | IARS2 interactions | MYH9 UBA1 AARS2 GNAI2 HSPA9 ACAD9 CRYZ ARL10 AIFM1 MTIF2 IFT122 RPA3 | 3.45e-04 | 273 | 271 | 12 | int:IARS2 |
| Interaction | SIRT6 interactions | MYCBP2 RNF40 ZNF318 SUPT5H SUPT6H ABCD3 MIOS HECTD1 KPNA1 FAT4 NUP98 AGPS SMC2 RAX CELSR1 AIFM1 RNF20 CCAR2 AATF CDC27 | 3.46e-04 | 628 | 271 | 20 | int:SIRT6 |
| GeneFamily | PDZ domain containing | HTRA1 SIPA1L3 MPDZ DLG1 DLG4 ARHGAP23 MYO18A GRIP2 SNTB1 PDZD2 | 3.10e-06 | 152 | 181 | 10 | 1220 |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 1.22e-05 | 15 | 181 | 4 | 696 | |
| GeneFamily | WD repeat domain containing | PPP2R2D PIK3R4 CORO7 PPP2R2A PPP2R2B PPP2R2C DNAAF10 IFT122 WDFY3 EML1 CFAP44 | 6.88e-05 | 262 | 181 | 11 | 362 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.97e-04 | 3 | 181 | 2 | 287 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 5.02e-04 | 16 | 181 | 3 | 14 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | GPHN CYP2A6 MPDZ DBT PHGDH ME3 SUPT5H SUPT6H HPS4 DHODH KATNIP ALDH3A2 MADD MLYCD LIG1 VPS13D MTOR AIFM1 IFT122 EIF3C SNTB1 | 6.16e-07 | 567 | 273 | 21 | M16909 |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | CMTR1 RNF40 UBA1 SUPT6H GNAI2 MYO18A OAS2 PDHX SLC4A2 ACIN1 CDC27 | 1.29e-06 | 164 | 273 | 11 | M5653 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | HTRA1 CFL2 CFB KLHL29 FAP DUOX1 ABCD3 MTMR2 C3 GNAI1 ALDH3A2 KPNA1 ARHGAP23 SH3KBP1 CCDC80 AGPS CBR1 TGFBI | 1.69e-06 | 457 | 273 | 18 | M14507 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | MYH9 MYCBP2 RAB11A SAMD12 PCDH19 DLG4 GNAI1 BSN PPP2R2C PLXNC1 ACIN1 EIF3C | 1.88e-06 | 206 | 273 | 12 | M2817 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | MYH9 MYCBP2 RAB11A SAMD12 PCDH19 DLG4 GNAI1 BSN PPP2R2C PLXNC1 ACIN1 EIF3C | 2.08e-06 | 208 | 273 | 12 | MM581 |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN | CMTR1 CFB KLHL29 IFIH1 C3 PRMT7 HSPA9 SERHL2 OAS2 NT5C2 DYNC1LI1 | 7.58e-06 | 197 | 273 | 11 | M9580 |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP | 8.75e-06 | 200 | 273 | 11 | M9299 | |
| Coexpression | GABRIELY_MIR21_TARGETS | MYCBP2 MPDZ MAP3K1 CEMIP2 NEK1 DLG1 HECTD1 NIPBL PTBP3 NEK7 REV3L SERAC1 LIMCH1 | 1.19e-05 | 289 | 273 | 13 | M2196 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | MYH9 HTRA1 HNMT STAT6 KLHL29 SUPT5H SUPT6H NLRC5 PYGB C3 ALDH3A2 TOGARAM2 MYO18A TGFBI CELSR1 SNTB1 | 1.42e-05 | 433 | 273 | 16 | M2240 |
| Coexpression | STEIN_ESRRA_TARGETS_UP | ARL2BP ACACB PPP2R2D SLC25A3 CKMT2 ALDH3A2 ILVBL WWC1 TACC2 SMC2 PPIC PDHX MLYCD MECR AIFM1 | 1.42e-05 | 385 | 273 | 15 | M18491 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MYCBP2 MDGA2 ZNF318 ACVR1B ACVR2A DCC TMEM132B RYR2 PCDH19 CGN BSN PTBP3 DIP2B ARHGAP23 SH3KBP1 KSR2 GRID2 REV3L PPP2R2B PPP2R2C SUGP2 GUCY1A1 PLXNC1 PLXNA4 TNK2 CHSY3 GRIP2 HYDIN | 1.47e-05 | 1106 | 273 | 28 | M39071 |
| Coexpression | SOGA_COLORECTAL_CANCER_MYC_UP | 2.40e-05 | 82 | 273 | 7 | M45007 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | MYH9 PPP2R2D CEMIP2 SAT1 CGN MIOS KIFC3 WWC1 KPNA1 PTBP3 CLIP2 ACAD9 DUSP6 MAP3K14 AGPS SMC2 SLC4A2 TGFBI NSUN5 WASH3P AIFM1 SLC7A5 WDFY3 | 2.83e-05 | 843 | 273 | 23 | M2356 |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | MAT2A INSR ST14 PHGDH CEMIP2 ABCD3 DLG1 GNAI1 PTBP3 DUSP6 COL5A3 TACC2 TGFBI PPP2R2A NCOA1 SLC7A5 EML1 | 3.00e-05 | 512 | 273 | 17 | M4508 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PHF20 ATR MYCBP2 ME2 PIK3R4 NEK1 TMEM131L DLG1 GNAI1 NIPBL WWC1 MAP3K14 NUP98 NEK7 REV3L PPP2R2A MTIF2 NT5C2 NCOA1 MACF1 AKAP11 WDFY3 CDC27 | 3.58e-05 | 856 | 273 | 23 | M4500 |
| Coexpression | CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL | 4.08e-05 | 195 | 273 | 10 | M39303 | |
| Coexpression | GSE17721_4H_VS_24H_POLYIC_BMDC_UP | 4.84e-05 | 199 | 273 | 10 | M4098 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 4.85e-05 | 124 | 273 | 8 | M7876 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN | RAB11B CMTR1 RNF40 HNMT SUPT5H SUPT6H FMO5 OAS2 SLC4A2 PLXNC1 | 5.05e-05 | 200 | 273 | 10 | M5977 |
| Coexpression | GSE17721_0.5H_VS_8H_CPG_BMDC_UP | TMEM205 ME2 SLC25A3 FAM120A GNAI2 DTYMK MAP3K14 MYO18A TGFBI ATP6V0D1 | 5.05e-05 | 200 | 273 | 10 | M4126 |
| Coexpression | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN | GPHN CYP2A6 ARL2BP ZNF318 DBT TUBGCP4 ALDH3A2 PTBP3 NAGK OAS2 PDHX PPP2R2A CRYZ MTIF2 MYLIP CDC27 RPA3 ATP5F1B | 5.28e-05 | 590 | 273 | 18 | M16066 |
| Coexpression | LIU_CMYB_TARGETS_UP | 5.87e-05 | 164 | 273 | 9 | M15066 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 | MYH9 CFL2 RAB11A NCAM2 FBP1 SAT1 MIOS TMEM131L SDC1 SERHL2 CCDC80 VPS13D NCOA1 LIMCH1 EML1 PDZD2 | 6.41e-05 | 491 | 273 | 16 | M13661 |
| Coexpression | PILON_KLF1_TARGETS_UP | INSR ME1 CFB CGN MIOS HECTD1 CX3CL1 MLPH HSPA9 WWC1 KPNA1 SUGP2 GUCY1A1 RNF20 NT5C2 SNTB1 | 8.50e-05 | 503 | 273 | 16 | M2226 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | PPP2R2D INSR SRP68 DPM1 PHGDH FAM120A ABCD3 MTMR2 DDX23 GNAI1 ILVBL ACAD9 DTYMK TSEN54 CEP192 DPP3 AGPS METTL4 SMC2 CBR1 PDHX LIG1 SUGP2 AIFM1 MTIF2 SLC7A5 ALYREF POLQ CDC27 RPA3 | 9.60e-05 | 1363 | 273 | 30 | M45782 |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT | 1.04e-04 | 24 | 273 | 4 | M38986 | |
| Coexpression | AMUNDSON_RESPONSE_TO_ARSENITE | CNPY2 ME1 STAT6 PIK3R4 KIFC3 HSPA9 REV3L ATP6V0D1 GUCY1A1 SLC7A5 | 1.08e-04 | 219 | 273 | 10 | M262 |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 1.15e-04 | 179 | 273 | 9 | M16932 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | HIP1 PHF20 ACACB SIPA1L3 INSR DCC PLEKHA5 KIFC3 DIP2B DPP10 PDHX NT5C2 ACIN1 PDZD2 | 1.35e-04 | 417 | 273 | 14 | M39224 |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | KBTBD3 CFL2 SAMD12 TMEM132B MTMR2 DLG1 KATNIP GNAI1 CARNS1 DIP2B ARHGAP23 SH3GL3 SH3KBP1 NEK7 AGPS CBR1 SLC4A2 HHIP PPP2R2A DNAH17 | 1.38e-04 | 754 | 273 | 20 | M39037 |
| Coexpression | STEIN_ESRRA_TARGETS | ARL2BP CMTR1 ACACB PPP2R2D SLC25A3 CKMT2 ALDH3A2 ILVBL WWC1 TACC2 SMC2 PPIC PDHX MLYCD MECR AIFM1 | 1.51e-04 | 529 | 273 | 16 | M843 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | GPHN MYCBP2 STK38 TUBGCP4 HNMT SLC25A3 CKMT2 DHODH ALDH3A2 HSPA9 DUSP6 NUP98 ARL10 | 1.89e-04 | 379 | 273 | 13 | M1885 |
| Coexpression | MOOTHA_HUMAN_MITODB_6_2002 | DBT ME2 ME3 SLC25A3 CKMT2 DHODH HSPA9 GRID2 PDHX MLYCD MTOR AIFM1 MTIF2 ATP5F1B | 1.94e-04 | 432 | 273 | 14 | M9433 |
| Coexpression | PILON_KLF1_TARGETS_UP | INSR ME1 CFB CGN MIOS HECTD1 CX3CL1 MLPH HSPA9 WWC1 KPNA1 SUGP2 GUCY1A1 RNF20 NT5C2 SNTB1 | 1.95e-04 | 541 | 273 | 16 | MM1061 |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | MYH9 ME1 PHGDH KIFC3 HECTD1 DTYMK CCDC80 TGFBI LRP4 AATF RPA3 | 2.09e-04 | 284 | 273 | 11 | M16975 |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | MYCBP2 RAB11A RYR2 ME3 SLC25A3 UBA1 PTPRN2 GNAI1 CX3CL1 NPTX1 PDHX MADD CLIP3 PPP2R2A ATP6V0D1 AKAP11 | 2.21e-04 | 547 | 273 | 16 | M2110 |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP | 2.27e-04 | 196 | 273 | 9 | M8858 | |
| Coexpression | GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP | 2.36e-04 | 197 | 273 | 9 | M4682 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 2.45e-04 | 198 | 273 | 9 | M9386 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 2.54e-04 | 199 | 273 | 9 | M9332 | |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 2.54e-04 | 199 | 273 | 9 | M312 | |
| Coexpression | GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP | 2.54e-04 | 199 | 273 | 9 | M8551 | |
| Coexpression | GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 2.54e-04 | 199 | 273 | 9 | M7496 | |
| Coexpression | HALLMARK_FATTY_ACID_METABOLISM | 2.62e-04 | 158 | 273 | 8 | M5935 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 2.64e-04 | 200 | 273 | 9 | M8208 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN | 2.64e-04 | 200 | 273 | 9 | M3638 | |
| Coexpression | GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN | 2.64e-04 | 200 | 273 | 9 | M8846 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_UP | 2.64e-04 | 200 | 273 | 9 | M3811 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 2.64e-04 | 200 | 273 | 9 | M6447 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN | 2.64e-04 | 200 | 273 | 9 | M6313 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 2.64e-04 | 200 | 273 | 9 | M8972 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 2.64e-04 | 200 | 273 | 9 | M5777 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP | 2.64e-04 | 200 | 273 | 9 | M4351 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN | 2.64e-04 | 200 | 273 | 9 | M5606 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_DN | 2.64e-04 | 200 | 273 | 9 | M10431 | |
| Coexpression | MOOTHA_GLUCONEOGENESIS | 2.90e-04 | 31 | 273 | 4 | M13448 | |
| Coexpression | GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN | 2.97e-04 | 161 | 273 | 8 | M8784 | |
| Coexpression | MOOTHA_MITOCHONDRIA | DBT ME2 MAP3K1 ME3 SLC25A3 CKMT2 DHODH PYGB HSPA9 PDHX MLYCD AIFM1 MTIF2 ATP5F1B | 3.00e-04 | 451 | 273 | 14 | M9577 |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | RAB11B TMEM205 DPM1 NSD3 STAT6 ARL6IP4 SLC25A3 GLMP FAM120A PLEKHA5 GNAI2 HECTD1 NAGK ASAP3 NT5C3B CR1 CBR1 HHIP MYLIP LRP6 ACIN1 ALYREF WDFY3 CDC27 | 3.06e-04 | 1055 | 273 | 24 | MM3677 |
| Coexpression | AIZARANI_LIVER_C11_HEPATOCYTES_1 | 3.16e-04 | 298 | 273 | 11 | M39115 | |
| Coexpression | MANALO_HYPOXIA_UP | 3.16e-04 | 205 | 273 | 9 | M259 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 3.37e-04 | 164 | 273 | 8 | M41676 | |
| Coexpression | BUSSLINGER_GASTRIC_PARIETAL_CELLS | DBT ME3 SLC25A3 CKMT2 HSPA9 ARRDC4 PDHX SLC4A2 AIFM1 ATP5F1B | 3.55e-04 | 254 | 273 | 10 | M40014 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | MYH9 MYCBP2 SIPA1L3 INSR NCAM2 EVX1 SIX4 ST14 NSD3 KLHL29 FAP TMEM131L PLEKHA5 FAT4 CUX2 DPP10 PCDHB7 GRID2 REV3L HHIP CLIP3 CELSR1 HMCN1 GUCY1A1 PLCH2 SERAC1 IFT122 CACNA2D3 PDZD2 | 5.85e-07 | 806 | 272 | 29 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | RAB11B CMTR1 PPP2R2D NCAM2 MDGA2 BTBD1 NEK1 FAM120A SUPT6H DLG1 GNAI1 HECTD1 NIPBL DYNC2H1 PTBP2 SMC2 LIG1 CLIP3 MTIF2 PLCH2 RNF20 MACF1 WDFY3 | 7.02e-06 | 629 | 272 | 23 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | MYH9 INSR EVX1 SIX4 KLHL29 FAP FAT4 CUX2 DPP10 PCDHB7 GRID2 REV3L HHIP CLIP3 PLCH2 SERAC1 CACNA2D3 | 2.19e-05 | 407 | 272 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 6.99e-05 | 137 | 272 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | SIX4 FAP TMEM131L FAT4 CUX2 DPP10 PCDHB7 GRID2 HMCN1 GUCY1A1 CACNA2D3 PDZD2 | 7.51e-05 | 243 | 272 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | MYCBP2 LAMA1 COL6A5 RYR2 CEMIP2 ADH4 DYNC2H1 CCDC80 REV3L PLXNA4 DYNC1LI1 MACF1 LIMCH1 PRKG1 | 3.13e-11 | 200 | 275 | 14 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | HIP1 CPED1 ST14 RYR1 FBP1 NAPSA CUX2 ZNF618 TGFBI PLXNA4 LIMCH1 CACNA2D3 | 3.55e-09 | 195 | 275 | 12 | 4cbc36fb3ef9aef61367d3b37070a9a85fae1418 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYCBP2 LAMA1 COL6A5 RYR2 ADH4 DYNC2H1 CCDC80 REV3L PLXNA4 MACF1 LIMCH1 PRKG1 | 4.46e-09 | 199 | 275 | 12 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GPHN DUOX1 C3 MLPH NAPSA FMO5 TACC2 HHIP GUCY1A1 LRP6 LIMCH1 PDZD2 | 4.46e-09 | 199 | 275 | 12 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | NUP210L NCAM2 MDGA2 DCC TMEM132B RYR1 RYR2 PTPRN2 CUX2 DPP10 GRID2 | 4.73e-09 | 159 | 275 | 11 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | GPHN DUOX1 MLPH WWC1 NAPSA FMO5 TACC2 HHIP GUCY1A1 LIMCH1 PDZD2 | 3.18e-08 | 191 | 275 | 11 | a0332a4ef629510fb313ec119195c44a3f704a80 |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | SAMD12 DUOX1 MLPH WWC1 NAPSA TACC2 CELSR1 LRP6 LIMCH1 PRKG1 PDZD2 | 3.36e-08 | 192 | 275 | 11 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | GPHN SAMD12 DUOX1 MLPH WWC1 NAPSA TACC2 HHIP LIMCH1 PRKG1 PDZD2 | 3.73e-08 | 194 | 275 | 11 | 53f3e49e91b1096f3226010e2de767efb490dfe4 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | UNC13D ME1 FBP1 KIFC3 SDC1 WWC1 NAPSA HEATR5A CELSR1 LIMCH1 CACNA2D3 | 5.10e-08 | 200 | 275 | 11 | 8683445ad5b70748c4a1f12eb77d47623085147e |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NCAM2 COL6A5 CPED1 ABCA9 RYR2 FAP FAT4 HMCN1 CHSY3 PRKG1 CACNA2D3 | 5.10e-08 | 200 | 275 | 11 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | UNC13D ME1 FBP1 C3 KIFC3 SDC1 WWC1 NAPSA HEATR5A LIMCH1 CACNA2D3 | 5.10e-08 | 200 | 275 | 11 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | UNC13D ME1 CGN KIFC3 WWC1 HEATR5A TACC2 CELSR1 LIMCH1 CACNA2D3 | 1.80e-07 | 179 | 275 | 10 | 04ce3673e46606f63d9c87bcba3a64c96817d812 |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ST14 MAP3K1 CEMIP2 BMX SDC1 SH3GL3 CELSR1 HMCN1 CCAR2 LIMCH1 | 1.99e-07 | 181 | 275 | 10 | cef034030e6b029a49ae56be37ea1fac1a5c350e |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | GPHN ACACB CEMIP2 BMX SDC1 SH3GL3 COL5A3 PPP2R2C C1QTNF9 SNTB1 | 1.99e-07 | 181 | 275 | 10 | 136b0c60680068838d184d32aa99d7bea8718dbc |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HTRA1 PHGDH SAT1 GNAI1 TGM3 PPP2R2C CELSR1 LRP4 SLC7A5 ADAMTS14 | 2.10e-07 | 182 | 275 | 10 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-07 | 183 | 275 | 10 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP3K1 KLHL29 WWC1 WNT7B SH3GL3 CELSR1 DNAH17 WDFY3 HYDIN SNTB1 | 2.21e-07 | 183 | 275 | 10 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.32e-07 | 184 | 275 | 10 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-07 | 186 | 275 | 10 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | HIP1 MDGA2 CPED1 RYR2 TMEM131L COL5A3 GRID2 GUCY1A1 CHSY3 PRKG1 | 2.70e-07 | 187 | 275 | 10 | 48bfdb3504c3fefe5db3abac4b790c369680ab4e |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-07 | 187 | 275 | 10 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | HIP1 MDGA2 CPED1 RYR2 TMEM131L COL5A3 GRID2 GUCY1A1 CHSY3 PRKG1 | 2.70e-07 | 187 | 275 | 10 | 958402fcc78f4c7a7d13d659d776f3817137975f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA9 CGN HECTD1 CLIP2 DYNC2H1 PPP2R2C HMCN1 LIMCH1 EMX1 CACNA2D3 | 2.70e-07 | 187 | 275 | 10 | f124d2c699b717b7c02a1a70493f515b83dc2f4c |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SAMD12 MDGA2 ADH4 BMX ARHGAP23 CCDC80 C1QTNF9 GRIP2 EML1 HYDIN | 2.83e-07 | 188 | 275 | 10 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA9 CGN HECTD1 CLIP2 DYNC2H1 PPP2R2C HMCN1 LIMCH1 EMX1 CACNA2D3 | 2.98e-07 | 189 | 275 | 10 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | ACACB RYR2 CKMT2 PLEKHA5 TACC2 GRIP2 LIMCH1 PRKG1 CACNA2D3 PDZD2 | 3.13e-07 | 190 | 275 | 10 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.28e-07 | 191 | 275 | 10 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.28e-07 | 191 | 275 | 10 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.44e-07 | 192 | 275 | 10 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.44e-07 | 192 | 275 | 10 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.61e-07 | 193 | 275 | 10 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.97e-07 | 195 | 275 | 10 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-07 | 196 | 275 | 10 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | critical-Epithelial-Secretory|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.16e-07 | 196 | 275 | 10 | 7da687eb983a54c28ee990424cc52e01caf5f4aa | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.16e-07 | 196 | 275 | 10 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.16e-07 | 196 | 275 | 10 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | SAMD12 PLEKHA5 WWC1 ERICH3 DYNC2H1 TACC2 CELSR1 LIMCH1 CFAP44 HYDIN | 4.16e-07 | 196 | 275 | 10 | 87d9881cfec461a5d89b688a83749b618c519485 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | MAT1A COL6A5 DCC RYR2 PCDH19 DYNC2H1 SLC17A8 LRP4 MACF1 LIMCH1 | 4.57e-07 | 198 | 275 | 10 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-07 | 198 | 275 | 10 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-07 | 199 | 275 | 10 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SIPA1L3 SAMD12 DUOX1 MLPH WWC1 TACC2 CELSR1 LIMCH1 SNTB1 PDZD2 | 4.79e-07 | 199 | 275 | 10 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-07 | 199 | 275 | 10 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.79e-07 | 199 | 275 | 10 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-07 | 199 | 275 | 10 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | UNC13D ME1 FBP1 KIFC3 SDC1 WWC1 HEATR5A CELSR1 LIMCH1 CACNA2D3 | 4.79e-07 | 199 | 275 | 10 | d43c605a4ff221cf78d91678c15d2ad20f831c7f |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | UNC13D FBP1 C3 KIFC3 SDC1 WWC1 NAPSA HEATR5A CELSR1 CACNA2D3 | 4.79e-07 | 199 | 275 | 10 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | LAMA1 COL6A5 ADH4 DYNC2H1 CCDC80 REV3L PLXNA4 MACF1 LIMCH1 PRKG1 | 5.01e-07 | 200 | 275 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.01e-07 | 200 | 275 | 10 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | UNC13D FBP1 C3 KIFC3 SDC1 WWC1 NAPSA HEATR5A CELSR1 CACNA2D3 | 5.01e-07 | 200 | 275 | 10 | ddfb1f006365bf16203ee49f20200f68220cc288 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.01e-07 | 200 | 275 | 10 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 5.01e-07 | 200 | 275 | 10 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.01e-07 | 200 | 275 | 10 | 16828c6a2be66bbbd805453325d6da719f2dea1b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.01e-07 | 200 | 275 | 10 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.01e-07 | 200 | 275 | 10 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 8.23e-07 | 163 | 275 | 9 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.58e-07 | 166 | 275 | 9 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 168 | 275 | 9 | b14fd50232887b6dca1f39014d43c6f66e5c3b5c | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.23e-06 | 171 | 275 | 9 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-06 | 177 | 275 | 9 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.88e-06 | 180 | 275 | 9 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-06 | 181 | 275 | 9 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 181 | 275 | 9 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 181 | 275 | 9 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-06 | 183 | 275 | 9 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP3K1 KLHL29 ALDH3A2 WNT7B SH3GL3 PPP2R2B DNAH17 PLXNA4 ADAMTS14 | 2.15e-06 | 183 | 275 | 9 | 83592c332b1e82673f993d37c7f480befdc3dcda |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 2.15e-06 | 183 | 275 | 9 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-06 | 183 | 275 | 9 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.15e-06 | 183 | 275 | 9 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 185 | 275 | 9 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 185 | 275 | 9 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 2.35e-06 | 185 | 275 | 9 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.46e-06 | 186 | 275 | 9 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-06 | 187 | 275 | 9 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.57e-06 | 187 | 275 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.68e-06 | 188 | 275 | 9 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.68e-06 | 188 | 275 | 9 | 8231e635706a296db6b6da1029a33bbc1b52478e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-06 | 188 | 275 | 9 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.68e-06 | 188 | 275 | 9 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.80e-06 | 189 | 275 | 9 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-06 | 189 | 275 | 9 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-06 | 189 | 275 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | (7)_Epithelial-D_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.93e-06 | 190 | 275 | 9 | 832d6d3ad14665e50623afe1b8586ccae1a97de5 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-06 | 190 | 275 | 9 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | LAMA1 MAP3K1 KLHL29 WWC1 SH3GL3 PPP2R2B DNAH17 PLXNA4 CACNA2D3 | 2.93e-06 | 190 | 275 | 9 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-06 | 191 | 275 | 9 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.05e-06 | 191 | 275 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.05e-06 | 191 | 275 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-06 | 191 | 275 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.05e-06 | 191 | 275 | 9 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-06 | 191 | 275 | 9 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.19e-06 | 192 | 275 | 9 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 3.19e-06 | 192 | 275 | 9 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.33e-06 | 193 | 275 | 9 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.33e-06 | 193 | 275 | 9 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.33e-06 | 193 | 275 | 9 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-06 | 193 | 275 | 9 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.47e-06 | 194 | 275 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-06 | 194 | 275 | 9 | 46266d3d9af7000dc1381b1c8e55047193cbcf94 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.62e-06 | 195 | 275 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.62e-06 | 195 | 275 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| Computational | Response to DNA damage. | MAT1A MAT2A STK38 ABCB4 ABCD3 DDX23 DTYMK MYO18A MSH5 LCK SMC2 LIG1 ATP5F1B | 2.38e-05 | 187 | 188 | 13 | MODULE_244 |
| Drug | magnesium | GPHN RAB11B ARL2BP TRIT1 MAT2A PAK4 INSR LAMA1 RAB11A ME2 DPM1 RYR1 CFB RYR2 ABCB4 CKMT2 FBP1 AARS2 KCNJ4 C3 ALDH3A2 MLPH ILVBL NAGK MTHFD1L DTYMK NT5C3B ACTRT2 DPP3 LCK PDHX LIG1 AIFM1 DNAAF10 DNAH17 NT5C2 DYNC1LI1 AATF ATP5F1B | 1.99e-07 | 1325 | 273 | 39 | CID000000888 |
| Drug | U0126 | INSR LAMA1 ME1 ME2 MAP3K1 ME3 STAT6 CKMT2 CGN DUSP6 SMC2 MADD TGFBI MTOR AIFM1 DNAAF10 TNF PRKG1 PRKG2 CDC27 | 2.87e-07 | 430 | 273 | 20 | CID000005637 |
| Drug | beta-NADP | CYP2A6 ME1 ME2 ME3 ADH4 DUOX1 FBP1 MTMR2 PYGB ALDH3A2 ILVBL HSD17B7 FMO5 MTHFD1L AGPS CBR1 PDHX CRYZ ATP6V0D1 MECR ACIN1 | 5.50e-07 | 490 | 273 | 21 | CID000000929 |
| Drug | Gvapspat amide | 6.50e-07 | 15 | 273 | 5 | CID000125015 | |
| Drug | AC1L1G3W | MAT1A MAT2A INSR HNMT RYR1 STAT6 NOD1 ALDH3A2 MAP3K14 GUCY1A1 TNF PRKG1 PRKG2 ATP5F1B | 1.15e-06 | 237 | 273 | 14 | CID000003514 |
| Drug | procymidone | 2.84e-06 | 155 | 273 | 11 | ctd:C035988 | |
| Drug | hydride | CYP2A6 MAT2A INSR DBT PHGDH RYR1 ADH4 SLC25A3 DUOX1 SAT1 DHODH C3 DLG4 ALDH3A2 ILVBL HSD17B7 FMO5 MTHFD1L AGPS CBR1 PDHX SLC4A2 CRYZ ATP6V0D1 MECR GUCY1A1 ATP5F1B | 3.19e-06 | 835 | 273 | 27 | CID000000783 |
| Drug | adenine | TRIT1 MAT1A MAT2A ME1 ME2 RYR1 RYR2 ME3 CKMT2 PYGB C3 NAPSA DPP10 MTHFD1L NT5C3B REV3L MTOR AIFM1 MTIF2 POLQ | 3.97e-06 | 510 | 273 | 20 | CID000000190 |
| Drug | NSC115907 | TRIT1 HIP1 ME1 ME2 ME3 CKMT2 DUOX1 AGPS PDHX CRYZ MTOR AIFM1 TNF ATP5F1B | 4.45e-06 | 266 | 273 | 14 | CID000005102 |
| Drug | AC1L1IZ2 | MYH9 MAT1A MAT2A INSR RYR1 RYR2 NAGK MYO18A ACTRT2 AGPS LCK LIG1 AIFM1 PRKG1 ATP5F1B | 4.45e-06 | 304 | 273 | 15 | CID000004795 |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; HL60; HT_HG-U133A | RAB11B HPS4 DLG1 PRMT7 ALDH3A2 DENND5B PTBP3 CR1 PLXNC1 NCOA1 LRP6 WDFY3 | 4.68e-06 | 196 | 273 | 12 | 2997_DN |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A | SIPA1L3 ACVR1B DBT RYR1 KLHL29 SUPT6H MIOS ASAP3 OAS2 VPS13D MTOR LIMCH1 | 4.68e-06 | 196 | 273 | 12 | 2851_UP |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; HL60; HT_HG-U133A | F5 RYR2 ABCB4 FBP1 PTPRN2 MLPH CLIP2 MAP3K14 OAS2 PLXNC1 DNAH17 SNTB1 | 4.93e-06 | 197 | 273 | 12 | 2491_DN |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | ZNF318 DBT IFIH1 NEK1 TMEM131L SERHL2 FAT4 ASAP3 MADD VPS13D WDFY3 CROCC | 5.19e-06 | 198 | 273 | 12 | 4621_DN |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A | ACACB MPDZ ACVR1B ACVR2A RYR2 MAP3K1 PTPRN2 PYGB CELSR1 TNK2 LIMCH1 SNTB1 | 5.47e-06 | 199 | 273 | 12 | 2956_UP |
| Drug | H2O2 | CYP2A6 HTRA1 PPP2R2D INSR RYR1 RYR2 MAP3K1 CKMT2 DUOX1 FBP1 SAT1 KCNJ4 DHODH ALDH3A2 HSPA9 ACTRT2 REV3L LCK SMC2 PPP2R2B PPP2R2C CRYZ ATP6V0D1 MTOR AIFM1 DNAAF10 LRP6 SLC7A5 TNF PRKG2 POLQ HAO2 | 1.54e-05 | 1183 | 273 | 32 | CID000000784 |
| Drug | pyruvic acid | MAT2A DBT ME1 ME2 ME3 CKMT2 FBP1 DHODH PYGB C3 ALDH3A2 ILVBL PDHX MLYCD TGFBI MECR HAO2 | 1.61e-05 | 424 | 273 | 17 | CID000001060 |
| Drug | NSC406942 | MAT2A INSR TUBGCP4 ME1 ME2 RYR1 RYR2 ME3 FBP1 DHODH PYGB BSN CORO7 HSPA9 NT5C3B ACTRT2 PDHX MTIF2 TNF IFT122 | 1.77e-05 | 565 | 273 | 20 | CID000001115 |
| Drug | I-Q-S | 1.97e-05 | 156 | 273 | 10 | CID000003540 | |
| Drug | AC1L2A54 | 2.07e-05 | 191 | 273 | 11 | CID000068636 | |
| Drug | NADP(H | CYP2A6 DBT ME1 ME2 ME3 ADH4 DUOX1 FBP1 PYGB ALDH3A2 ILVBL HSD17B7 FMO5 MTHFD1L AGPS CBR1 CRYZ MECR ACIN1 | 2.25e-05 | 527 | 273 | 19 | CID000000930 |
| Drug | AC1L1D8L | 2.28e-05 | 71 | 273 | 7 | CID000002241 | |
| Drug | prochloraz | PAK4 MDGA2 DCC ADH4 DLG1 DLG4 BSN ERICH3 DPP10 CBR1 LENG9 IFT122 CACNA2D3 | 2.32e-05 | 268 | 273 | 13 | ctd:C045362 |
| Drug | BAS 012416453; Down 200; 38uM; PC3; HT_HG-U133A | ACACB DBT ME3 NOD1 HPS4 GNAI1 NIPBL WWC1 PTBP2 MAP3K14 PDZD2 | 2.39e-05 | 194 | 273 | 11 | 6876_DN |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A | RAB11B INSR NOD1 PTBP3 FMO5 MLYCD ADGB VPS13D PLXNC1 WDFY3 SNTB1 | 2.89e-05 | 198 | 273 | 11 | 3003_DN |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A | RAB11B HIP1 ACVR1B RYR2 MAP3K1 HPS4 FMO5 OAS2 PLXNC1 LIMCH1 EML1 | 2.89e-05 | 198 | 273 | 11 | 2272_DN |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | PHF20 RYR2 KLHL29 IFIH1 PTPRN2 KIFC3 TGFBI GUCY1A1 PLXNC1 DNAH17 EMX1 | 2.89e-05 | 198 | 273 | 11 | 6328_UP |
| Drug | Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; HL60; HG-U133A | ATR INSR DBT NEK1 SUPT6H MTMR2 KPNA1 PTBP3 DYNC2H1 COL5A3 TNK2 | 3.17e-05 | 200 | 273 | 11 | 1387_UP |
| Drug | CCK-J | 3.32e-05 | 6 | 273 | 3 | CID000132626 | |
| Drug | MeSAdo | 4.23e-05 | 137 | 273 | 9 | CID000000149 | |
| Drug | pyrophosphate | TRIT1 MYH9 MAT1A MAT2A SRP68 DPM1 CKMT2 UBA1 AARS2 DHODH FMO5 MYO18A REV3L LCK PDHX LIG1 GUCY1A1 LRP4 WDFY3 POLQ CDC27 | 4.56e-05 | 654 | 273 | 21 | CID000001023 |
| Drug | lactate | MAT2A ME1 ME2 RYR1 ME3 SLC25A3 CKMT2 FBP1 PYGB ILVBL PDHX MLYCD TGFBI LIG1 TNF HAO2 ATP5F1B | 4.61e-05 | 461 | 273 | 17 | CID000000612 |
| Drug | glyoxylate | 5.51e-05 | 176 | 273 | 10 | CID000000760 | |
| Drug | sodium;hexadecane | 6.64e-05 | 36 | 273 | 5 | CID000172416 | |
| Drug | imatinib | HIP1 INSR LAMA1 ACVR1B NSD3 BLK BMX NUP98 MYO18A LCK TGFBI MTOR AIFM1 TNK2 TNF PRKG2 | 6.93e-05 | 430 | 273 | 16 | CID000005291 |
| Drug | polyethylene glycol | CYP2A6 MAT1A CFL2 PAK4 RAB11A F5 ST14 RYR1 ADH4 MTMR2 C3 UHRF2 LCK | 7.15e-05 | 299 | 273 | 13 | CID000000174 |
| Drug | NSC717865 | RAB11B INSR ACVR1B ACVR2A DPM1 RYR1 RYR2 ABCB4 HPS4 ACTRT2 PPIC TGFBI MTOR DNAAF10 TNF | 7.42e-05 | 387 | 273 | 15 | CID000005372 |
| Disease | cortical thickness | MYCBP2 NUP210L LAMA1 ZNF318 BTBD1 ME1 CPED1 ME2 MAP3K1 KLHL29 DUOX1 MTMR2 PYGB GNAI2 DIP2B ARRDC4 PTBP2 TACC2 ACTRT2 HHIP PPP2R2A VPS13D CELSR1 PLXNC1 LRP4 MACF1 EML1 SNTB1 CACNA2D3 PDZD2 | 8.00e-08 | 1113 | 263 | 30 | EFO_0004840 |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.89e-06 | 12 | 263 | 4 | DOID:1441 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 8.96e-06 | 32 | 263 | 5 | C0345958 | |
| Disease | Intellectual Disability | RAB11B LAMA1 RAB11A DCC FCSK DLG4 ALDH3A2 CUX2 TSEN54 PDHX MTOR NT5C2 ACIN1 MACF1 SERAC1 | 1.34e-05 | 447 | 263 | 15 | C3714756 |
| Disease | Age-related macular degeneration | 1.71e-05 | 18 | 263 | 4 | cv:C0242383 | |
| Disease | amyloid-beta measurement | SAMD12 TMEM132B RYR1 KLHL29 PTPRN2 GNAI1 DPP10 TOGARAM2 ACTRT2 CR1 NCOA1 CACNA2D3 PDZD2 | 2.05e-05 | 355 | 263 | 13 | EFO_0005194 |
| Disease | coronary artery disease | HTRA1 MAT2A UNC13D CNPY2 CFB MAP3K1 IFIH1 FAP CCM2 ZC3H12D GNAI2 BSN CORO7 FAT4 CUX2 DPP10 APOA5 DYNC2H1 MTHFD1L KSR2 ACTRT2 PPP2R2A GUCY1A1 NT5C2 PRKG1 EML1 | 2.77e-05 | 1194 | 263 | 26 | EFO_0001645 |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 6.73e-05 | 25 | 263 | 4 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Short rib-polydactyly syndrome, Majewski type | 7.91e-05 | 2 | 263 | 2 | cv:CN305384 | |
| Disease | age related macular degeneration 7 (is_implicated_in) | 7.91e-05 | 2 | 263 | 2 | DOID:0110019 (is_implicated_in) | |
| Disease | Cardiac arrhythmia | 7.91e-05 | 2 | 263 | 2 | cv:C0003811 | |
| Disease | erythema nodosum (is_marker_for) | 7.91e-05 | 2 | 263 | 2 | DOID:0080750 (is_marker_for) | |
| Disease | boutonneuse fever (is_marker_for) | 7.91e-05 | 2 | 263 | 2 | DOID:14095 (is_marker_for) | |
| Disease | anterior uveitis (is_marker_for) | 7.91e-05 | 2 | 263 | 2 | DOID:1407 (is_marker_for) | |
| Disease | conjunctivitis (is_marker_for) | 7.91e-05 | 2 | 263 | 2 | DOID:6195 (is_marker_for) | |
| Disease | Genetic cardiac rhythm disease | 7.91e-05 | 2 | 263 | 2 | cv:C5681782 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 8.72e-05 | 157 | 263 | 8 | DOID:224 (biomarker_via_orthology) | |
| Disease | Hemolytic-Uremic Syndrome | 1.10e-04 | 11 | 263 | 3 | C0019061 | |
| Disease | thalamus volume | 1.15e-04 | 85 | 263 | 6 | EFO_0006935 | |
| Disease | Age related macular degeneration | 1.41e-04 | 30 | 263 | 4 | C0242383 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.82e-04 | 32 | 263 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | gamma-glutamylleucine measurement | 1.87e-04 | 13 | 263 | 3 | EFO_0021140 | |
| Disease | dilated cardiomyopathy 1H (is_marker_for) | 2.36e-04 | 3 | 263 | 2 | DOID:0110429 (is_marker_for) | |
| Disease | complement C3D fragment measurement | 2.36e-04 | 3 | 263 | 2 | EFO_0020277 | |
| Disease | esophageal carcinoma (is_marker_for) | 2.36e-04 | 3 | 263 | 2 | DOID:1107 (is_marker_for) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.36e-04 | 3 | 263 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.36e-04 | 3 | 263 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | sickle cell anemia (is_marker_for) | 2.37e-04 | 14 | 263 | 3 | DOID:10923 (is_marker_for) | |
| Disease | carcinoma (implicated_via_orthology) | 2.69e-04 | 64 | 263 | 5 | DOID:305 (implicated_via_orthology) | |
| Disease | colon cancer (is_implicated_in) | 2.90e-04 | 36 | 263 | 4 | DOID:219 (is_implicated_in) | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 2.94e-04 | 15 | 263 | 3 | DOID:1928 (implicated_via_orthology) | |
| Disease | eosinophil count | ATR SIPA1L3 SAMD12 UNC13D ACVR2A ME2 STAT6 ADH4 IFIH1 FAP CCM2 SUPT5H ZC3H12D NLRC5 GNAI2 CORO7 UHRF2 CX3CL1 D2HGDH DIP2B CUX2 NAGK MAP3K14 OAS2 CELSR1 PLXNC1 SLC7A5 | 3.89e-04 | 1488 | 263 | 27 | EFO_0004842 |
| Disease | amino acid measurement | ACACB ACVR2A RYR2 KLHL29 PTPRN2 GNAI1 PTBP3 FAT4 ARRDC4 TACC2 MLYCD LIG1 DYNC1LI1 GRIP2 PRKG1 SNTB1 | 4.25e-04 | 678 | 263 | 16 | EFO_0005134 |
| Disease | lupus nephritis (is_marker_for) | 4.34e-04 | 17 | 263 | 3 | DOID:0080162 (is_marker_for) | |
| Disease | Colonic Neoplasms | 4.45e-04 | 152 | 263 | 7 | C0009375 | |
| Disease | Familial intrahepatic cholestasis of pregnancy | 4.69e-04 | 4 | 263 | 2 | C3489728 | |
| Disease | silicosis (is_implicated_in) | 4.69e-04 | 4 | 263 | 2 | DOID:10325 (is_implicated_in) | |
| Disease | lepromatous leprosy (is_marker_for) | 4.69e-04 | 4 | 263 | 2 | DOID:10887 (is_marker_for) | |
| Disease | cochlear disease (biomarker_via_orthology) | 4.69e-04 | 4 | 263 | 2 | DOID:5463 (biomarker_via_orthology) | |
| Disease | factor VIII deficiency (is_marker_for) | 4.69e-04 | 4 | 263 | 2 | DOID:12134 (is_marker_for) | |
| Disease | Malignant tumor of colon | 5.83e-04 | 159 | 263 | 7 | C0007102 | |
| Disease | Colorectal Carcinoma | CYP2A6 LAMA1 DCC F5 ABCA9 ABCB4 PTPRN2 ABCD3 UHRF2 MTHFD1L ASAP3 GRID2 LIG1 HHIP ACIN1 TNF | 6.17e-04 | 702 | 263 | 16 | C0009402 |
| Disease | creatinine measurement | SIPA1L3 ACVR2A ST14 RYR1 BLK FAP DUOX1 TMEM131L DLG1 BSN PRMT7 ALDH3A2 UHRF2 DENND5B CUX2 WNT7B MAP3K14 PLXNC1 TNK2 RPA3 | 6.58e-04 | 995 | 263 | 20 | EFO_0004518 |
| Disease | Liver carcinoma | MAT1A ME1 ABCB4 ADH4 FBP1 HSPA9 MSH5 CBR1 TGM3 HHIP MTOR TNF HAO2 | 6.86e-04 | 507 | 263 | 13 | C2239176 |
| Disease | IgA glomerulonephritis (is_marker_for) | 7.13e-04 | 20 | 263 | 3 | DOID:2986 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 7.19e-04 | 268 | 263 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | HIP1 INSR UNC13D ZNF318 CFB NSD3 PIK3R4 KLHL29 FCSK SUPT6H CORO7 DIP2B CUX2 DYNC2H1 ZNF618 NEK7 HEATR5A MSH5 MADD GUCY1A1 PLXNC1 NT5C2 TNF EML1 HYDIN | 7.42e-04 | 1392 | 263 | 25 | EFO_0005763 |
| Disease | Familial ventricular tachycardia | 7.78e-04 | 5 | 263 | 2 | C0340485 | |
| Disease | response to statin, myocardial infarction | 7.78e-04 | 5 | 263 | 2 | EFO_0000612, GO_0036273 | |
| Disease | portal hypertension (biomarker_via_orthology) | 9.51e-04 | 22 | 263 | 3 | DOID:10762 (biomarker_via_orthology) | |
| Disease | Parkinson Disease | 9.94e-04 | 85 | 263 | 5 | C0030567 | |
| Disease | colorectal cancer | HIP1 UNC13D CCM2 PTPRN2 DENND5B PTBP3 DIP2B DPP10 WNT7B HHIP MACF1 MPHOSPH8 CFAP44 PDZD2 | 1.14e-03 | 604 | 263 | 14 | MONDO_0005575 |
| Disease | GlcNAc sulfate conjugate of C21H34O2 steroid measurement | 1.16e-03 | 6 | 263 | 2 | EFO_0800663 | |
| Disease | generalised epilepsy | 1.19e-03 | 52 | 263 | 4 | EFO_0005917 | |
| Disease | uric acid measurement | SIPA1L3 INSR ZNF318 ACVR2A F5 NSD3 FAP CCM2 PYGB FAT4 NPTX1 CUX2 DYNC2H1 CACNA2D3 | 1.25e-03 | 610 | 263 | 14 | EFO_0004761 |
| Disease | coffee consumption measurement | 1.28e-03 | 182 | 263 | 7 | EFO_0006781 | |
| Disease | Malignant neoplasm of prostate | CYP2A6 ATR UNC13D ST14 PHGDH MAP3K1 CX3CL1 NAGK COL5A3 CBR1 SLC4A2 PPP2R2A NCOA1 CDC27 | 1.37e-03 | 616 | 263 | 14 | C0376358 |
| Disease | Prostatic Neoplasms | CYP2A6 ATR UNC13D ST14 PHGDH MAP3K1 CX3CL1 NAGK COL5A3 CBR1 SLC4A2 PPP2R2A NCOA1 CDC27 | 1.37e-03 | 616 | 263 | 14 | C0033578 |
| Disease | ER membrane protein complex subunit 4 measurement | 1.61e-03 | 7 | 263 | 2 | EFO_0801580 | |
| Disease | Cerebral ventriculomegaly | 1.61e-03 | 7 | 263 | 2 | C1531647 | |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 1.61e-03 | 7 | 263 | 2 | DOID:0050592 (is_implicated_in) | |
| Disease | Communicating Hydrocephalus | 1.61e-03 | 7 | 263 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 1.61e-03 | 7 | 263 | 2 | C2936718 | |
| Disease | Obstructive Hydrocephalus | 1.61e-03 | 7 | 263 | 2 | C0549423 | |
| Disease | Hydrocephalus Ex-Vacuo | 1.61e-03 | 7 | 263 | 2 | C0270720 | |
| Disease | myocarditis (biomarker_via_orthology) | 1.61e-03 | 7 | 263 | 2 | DOID:820 (biomarker_via_orthology) | |
| Disease | Post-Traumatic Hydrocephalus | 1.61e-03 | 7 | 263 | 2 | C0477432 | |
| Disease | ascending aortic diameter | 1.64e-03 | 140 | 263 | 6 | EFO_0021787 | |
| Disease | vital capacity | HTRA1 UNC13D SIX4 DCC RYR2 MAP3K1 DLG1 CARNS1 DIP2B MAP3K14 TSEN54 AGPS HHIP HMCN1 AIFM1 NCOA1 LRP6 CCAR2 CHSY3 PRKG1 CACNA2D3 PDZD2 | 1.72e-03 | 1236 | 263 | 22 | EFO_0004312 |
| Disease | hypertension | 1.84e-03 | 307 | 263 | 9 | EFO_0000537 | |
| Disease | mean arterial pressure, alcohol drinking | 1.87e-03 | 98 | 263 | 5 | EFO_0004329, EFO_0006340 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.94e-03 | 28 | 263 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | CYP2A6 CFL2 ABCA9 CFB ABCB4 PYGB DIP2B APOA5 ASAP3 HEATR5A DPP3 MLYCD MYLIP SLC17A8 HYDIN | 1.99e-03 | 713 | 263 | 15 | EFO_0005689 |
| Disease | Insulin Sensitivity | 2.03e-03 | 60 | 263 | 4 | C0920563 | |
| Disease | Insulin Resistance | 2.03e-03 | 60 | 263 | 4 | C0021655 | |
| Disease | balding measurement | TRIT1 MYCBP2 MPDZ UNC13D TMEM131L KRT25 SDC1 DIP2B ZNF618 WNT7B KSR2 MAP3K14 ACTRT2 REV3L MTOR LRP6 | 2.14e-03 | 792 | 263 | 16 | EFO_0007825 |
| Disease | pneumococcal meningitis | 2.14e-03 | 8 | 263 | 2 | EFO_1001114 | |
| Disease | McCune Albright syndrome (implicated_via_orthology) | 2.14e-03 | 8 | 263 | 2 | DOID:1858 (implicated_via_orthology) | |
| Disease | anterior uveitis (is_implicated_in) | 2.14e-03 | 8 | 263 | 2 | DOID:1407 (is_implicated_in) | |
| Disease | benign neoplasm (implicated_via_orthology) | 2.14e-03 | 8 | 263 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Aqueductal Stenosis | 2.14e-03 | 8 | 263 | 2 | C2936786 | |
| Disease | Cholestasis of pregnancy | 2.14e-03 | 8 | 263 | 2 | C0268318 | |
| Disease | Inherited susceptibility to asthma | 2.14e-03 | 8 | 263 | 2 | cv:C1869116 | |
| Disease | Congenital Hydrocephalus | 2.14e-03 | 8 | 263 | 2 | C0020256 | |
| Disease | Venous Thromboembolism | 2.14e-03 | 8 | 263 | 2 | C1861172 | |
| Disease | ASTHMA, SUSCEPTIBILITY TO | 2.14e-03 | 8 | 263 | 2 | 600807 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 2.14e-03 | 8 | 263 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | neurotic disorder | 2.14e-03 | 101 | 263 | 5 | EFO_0004257 | |
| Disease | cerebral infarction (is_implicated_in) | 2.16e-03 | 29 | 263 | 3 | DOID:3526 (is_implicated_in) | |
| Disease | erythrocyte measurement | 2.26e-03 | 257 | 263 | 8 | EFO_0005047 | |
| Disease | optic disc size measurement | 2.52e-03 | 205 | 263 | 7 | EFO_0004832 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.62e-03 | 31 | 263 | 3 | C1335167 | |
| Disease | fatty liver disease (implicated_via_orthology) | 2.62e-03 | 31 | 263 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | serum albumin measurement | CYP2A6 INSR ABCA9 ADH4 DHODH DLG4 BSN SH3KBP1 MAP3K14 ASAP3 MADD MLYCD MACF1 | 2.71e-03 | 592 | 263 | 13 | EFO_0004535 |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 2.73e-03 | 65 | 263 | 4 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | Atypical hemolytic-uremic syndrome | 2.73e-03 | 9 | 263 | 2 | cv:C2931788 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 2.73e-03 | 9 | 263 | 2 | EFO_0010613 | |
| Disease | Carcinoma, Small Cell | 2.73e-03 | 9 | 263 | 2 | C0262584 | |
| Disease | neural tube defect (implicated_via_orthology) | 2.73e-03 | 9 | 263 | 2 | DOID:0080074 (implicated_via_orthology) | |
| Disease | C3 glomerulopathy | 2.73e-03 | 9 | 263 | 2 | C4087273 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQLKELLGRTGTLVE | 1026 | Q9UKV3 | |
| GGIGALVRLKSLQGD | 581 | Q15582 | |
| GGEKQRVFTGIVTSL | 51 | Q8N163 | |
| SLENITALRKEGGGE | 1166 | Q5RHP9 | |
| GKTNVILLGDSIGDL | 221 | Q969T7 | |
| FGGLLGEKTQDLIGV | 726 | P04920 | |
| GELLATGDKGGRVVI | 36 | Q00005 | |
| GELLATGDKGGRVVI | 36 | Q9Y2T4 | |
| LEEKERALQGSLGGV | 831 | O75150 | |
| RALQGSLGGVEKELT | 836 | O75150 | |
| LEGFKEGGIQLRLRS | 161 | Q6UXG8 | |
| LLKGRALVGTVNEAG | 641 | Q8TDY4 | |
| LLQSNIGTGEKELGL | 811 | Q5VTR2 | |
| IGTGEKELGLRTQAL | 816 | Q5VTR2 | |
| SIATLRDFGVGKRGI | 131 | P11509 | |
| LGGRKILFIGDSTNR | 766 | A4D0V7 | |
| FGEGTVLRQVDTKTG | 296 | P49902 | |
| ELLATGDKGGRVVIF | 41 | P63151 | |
| IQKILFGEIVLSGGT | 291 | Q8TDY3 | |
| VILGKGTDEQTDFGL | 576 | Q8N7X0 | |
| GASRIIGIDINSEKF | 221 | P08319 | |
| GGKIDNSVLVLIVGL | 61 | O95831 | |
| GQNRKLTFGIAILGD | 621 | Q8IUA7 | |
| TIVLQEIIGKGRFGE | 206 | P36896 | |
| EITLLKELGSGQFGV | 416 | P51813 | |
| ILQFIGAEKRGTSVD | 246 | P27037 | |
| TKIITGGAAAQDGRL | 256 | Q12959 | |
| LDGGQLGTLVGKRVS | 11 | P49640 | |
| KFSIGTIDGEVRLTG | 2096 | Q6V0I7 | |
| QAIGLKGIILAGTEE | 146 | Q9H845 | |
| GSGEVVLSRKVLLDG | 296 | P01024 | |
| LGLRLVELSGKEGQE | 126 | A5YM72 | |
| GDLLATGDKGGRVVI | 46 | Q66LE6 | |
| EGLGQDGKTLLITNI | 1801 | Q9UKA4 | |
| ILSLLEGQKIAFGGE | 291 | P51648 | |
| LRVVGEDTKAQLLGG | 151 | Q6Q788 | |
| EKDLRLGDRVLVGGT | 216 | Q9UDT6 | |
| ENFLETIGVKDGRGI | 366 | Q9BSQ5 | |
| TIGVKDGRGIITDSF | 371 | Q9BSQ5 | |
| ELELGAGVRLKTRGD | 151 | Q7Z6K5 | |
| VRDEGIQKLGVSSGL | 2766 | Q9NYQ6 | |
| ALAVLGAGGEEVKLQ | 1421 | Q96M86 | |
| EKEGRGLDLSSGLVV | 131 | Q9Y2Y0 | |
| QRIFGEKVLGLSQGS | 916 | O14529 | |
| GVTDINLGKLVRGDA | 181 | Q6UB35 | |
| QGSLGRFGKTITTDI | 311 | Q96MT7 | |
| LRLTSSGKEEIIFNG | 211 | Q8N608 | |
| LGGNEIVSFLKGLLT | 241 | O60762 | |
| LLGLVGDQLGDTERK | 236 | Q8WXS8 | |
| TEGLVRGQKVLDSGA | 116 | P06576 | |
| LRLLEKLGDGSFGVV | 126 | Q07912 | |
| EGGKVRRITSEGQIL | 196 | Q76M96 | |
| VGAEGRVKSLGLVFE | 11 | Q8NCT1 | |
| GGTRSEVLLVSEDGK | 11 | Q9UJ70 | |
| LIGDSGVGKSNLLSR | 16 | P62491 | |
| LIGDSGVGKSNLLSR | 16 | Q15907 | |
| RGSFVGNIAKDLGLE | 41 | Q9Y5H1 | |
| ILGTAGTEEGQKIVL | 176 | Q08257 | |
| AREVKLLLLGAGESG | 31 | P63096 | |
| KSRLLQDSGGRLVGV | 721 | Q9Y5G5 | |
| EKELNLILTTGGTGF | 76 | Q9NQX3 | |
| LAGVESRQGSIKGLV | 11 | Q96P11 | |
| LEETSGLKILQTGVG | 581 | Q92932 | |
| ALDRLFVIGGKTRGS | 401 | Q8NAB2 | |
| LGLEAGSKEEAGIIR | 401 | P48050 | |
| QVLSRVNTLEEGKGG | 176 | Q15818 | |
| IIGKDDGLGVENLRG | 1896 | O00763 | |
| EQREVLVLGLDGAGK | 76 | Q8N8L6 | |
| GVEIKGGSFRLLQEG | 41 | P00751 | |
| VENLRGALKESGLSI | 726 | Q9NRD9 | |
| RGQVVQFKLSDIGEG | 61 | P11182 | |
| NELFGLEIKTRGDGS | 171 | Q8TAB3 | |
| EEKGVDRLLGLGSAS | 111 | Q9BU76 | |
| GGSNLRILGVVKSDE | 381 | P43146 | |
| KSTLALQLGQRLGGE | 36 | Q9H3H1 | |
| VGEGLNRKAEVTLDG | 811 | P52948 | |
| GFSVTLKEDGVRGLA | 106 | Q00325 | |
| LFTKDGVRLGTVGEQ | 306 | Q9HBG6 | |
| KAIVVTDGERILGLG | 146 | P48163 | |
| LKTGEGGLLQVTLEG | 1551 | Q8WXG6 | |
| GGLLQVTLEGINLKF | 1556 | Q8WXG6 | |
| LTKDGTVQLGDFGIA | 136 | Q96PY6 | |
| EGTVIESFTDKGRGL | 356 | P46199 | |
| KAEGGGRLQALRSLS | 511 | Q8IX03 | |
| LGLTGLEVVGKEGQA | 1226 | O60303 | |
| KLSDFNIIDTLGVGG | 356 | Q13976 | |
| QGDAGLTGRKIIVDT | 256 | P31153 | |
| KGLIRAFEDGGIDSV | 211 | Q8NCR3 | |
| LEIGELIGKGRFGQV | 666 | Q6VAB6 | |
| RGEVLGLSSSLGKEL | 346 | Q9NQG7 | |
| SGTLQGGLRRFKTIE | 921 | Q9UPA5 | |
| LLLGEDGAGKTSLIR | 71 | Q9Y6G9 | |
| QGLQGVELGTFLIKR | 296 | O95822 | |
| RSTLGEKLGGNVVVS | 146 | Q9Y281 | |
| KEIINAIDGIGGLGI | 111 | Q96MX6 | |
| DSGLLVLAGKGERQL | 271 | P57737 | |
| DTGLVLLTGKGDTRV | 741 | P57737 | |
| NGLVGELVFKRADIG | 506 | O43424 | |
| GGAGEIDLQILSKVQ | 61 | P50135 | |
| EGGTKVTIRGENLGL | 871 | Q9HCM2 | |
| FLGTGDGQLLKVILG | 391 | O60486 | |
| RTTLLGGKEAQALGV | 271 | Q96B70 | |
| GDGLQELAVVSLKGV | 376 | Q9Y664 | |
| GLIGKVLQGVESRED | 226 | Q8NGJ8 | |
| EEGSKNIRLGSLIGL | 116 | O00330 | |
| LKGEEGSFRGSVLQR | 106 | Q92614 | |
| ELLKESDGLGIQVSG | 336 | O15018 | |
| ATGVVKLGDLGLGRF | 171 | Q8TDX7 | |
| QGSIERILKQVSGGE | 1631 | Q6KC79 | |
| LTRKDAGGQQIGFLL | 436 | Q9P265 | |
| GISTEGGKSLARALQ | 851 | Q9Y239 | |
| GFTVNERGLLSGNEK | 66 | Q7Z3Z0 | |
| GKITRQEFIDGILAS | 3186 | O94854 | |
| IILLGFVQIGKGDVS | 211 | Q01650 | |
| SVRDSEGQKLLIGVG | 191 | Q8WY64 | |
| TRLDGRSVGVVLKGE | 1041 | O75581 | |
| QGDAGVTGRKIIVDT | 256 | Q00266 | |
| DASLGVINRVEKIGG | 126 | Q13614 | |
| QVLKSTGDVAGGRAL | 626 | Q9NY33 | |
| DGKGTLLIRNGSEVR | 31 | P06239 | |
| GFEKGEQLRILEQSG | 81 | P06239 | |
| GIGGLTGKQLRELQD | 226 | Q9UGJ1 | |
| KRQGASFIGILDIAG | 441 | P35579 | |
| VELQKLARGSLVGGG | 21 | Q9NZB2 | |
| EKITLLRELGQGSFG | 1021 | P06213 | |
| VQLLGRGFIAGIDLK | 296 | Q9BUQ8 | |
| IRGEIGSGNFSQVKL | 76 | Q8IY84 | |
| KTVLRGNSDGTLVLF | 66 | P29728 | |
| GIETLGGVFTKLINR | 446 | P38646 | |
| GRLEVFQGEKLLSSI | 211 | Q13237 | |
| GEVALRGLETGKVIF | 461 | Q86WI3 | |
| LKGGGISDISIDVNI | 421 | Q7Z553 | |
| GGRTLQIIRAKVSDG | 3016 | Q96RW7 | |
| KFDTLVGERGAQLSG | 521 | P21439 | |
| EGRKARGTGELTQLL | 21 | P09467 | |
| RGTFLTNLAKDLGLG | 41 | Q9Y5E2 | |
| TNLAKDLGLGVGELR | 46 | Q9Y5E2 | |
| QASGGIVLQLKLGDE | 286 | P0C862 | |
| IQSSGRAKELLGQGL | 636 | Q99613 | |
| EKRVGSGGATLNALL | 51 | Q8N0W3 | |
| EDKNRLLRTVAGGGL | 991 | Q8NCM8 | |
| TESVKALGGLLGRQV | 1696 | Q8NCM8 | |
| LTTGDIGRAAKGDLV | 871 | Q13535 | |
| AVGKEAGELRTGLQE | 1256 | Q5TZA2 | |
| KGGDIFLDQLARLGV | 606 | Q9ULT8 | |
| KGERSVEESAGLVGL | 86 | Q96HJ9 | |
| IGQGRLSTDTLGKLA | 2116 | Q4G0P3 | |
| SFILRTTIGGLLGEK | 356 | Q86XA9 | |
| IVSTTQRGGKELGLR | 296 | Q92743 | |
| GSFEVISGRLLKREG | 126 | Q5T6J7 | |
| GDVGSFVLKLVEGLQ | 396 | A1L0T0 | |
| NLGSRGRKVFELVGE | 1096 | P17927 | |
| EKIELGGVRGNLLGS | 441 | Q9UFH2 | |
| DRGQKALVLDIGTGT | 61 | Q9NVM4 | |
| KGVEVAFLGTRTGLS | 721 | Q8IZS8 | |
| KRVIIIGIGNSGGDL | 186 | P49326 | |
| ELLSDVRFVLGKGRG | 66 | Q9H0C5 | |
| LRLVRKLGSGQFGEV | 241 | P51451 | |
| AGRKGVDTVGESILI | 481 | O75417 | |
| FRGLALTVGLKGEEG | 1696 | A8TX70 | |
| QGIRIDSDISGTLKF | 121 | Q9Y2B0 | |
| KETLNIVLVGRSGTG | 436 | Q8ND71 | |
| RVIGLSGDTQLKISF | 386 | Q9BYX4 | |
| GKGIDDGSLERILIG | 1031 | Q6ZUT9 | |
| ETGRTRLIKGDGEVL | 191 | Q66PJ3 | |
| GTNGLLIKDTIGFDT | 586 | Q9UHN6 | |
| EGLLTQGDKITADGL | 121 | P56937 | |
| TGGNKGIGLAIVRDL | 11 | P16152 | |
| FGLSVVLLKRNAGGE | 301 | P0C7T7 | |
| GELRKGDQILSVNGV | 351 | P78352 | |
| FGLLGEKTRQVSLEV | 31 | Q8WWB7 | |
| KAVVVTDGERILGLG | 156 | P23368 | |
| KAVVVTDGERILGLG | 181 | Q16798 | |
| EGKSIAIRLIGEALG | 2521 | Q8TEP8 | |
| GKSSTELLRQLARGG | 266 | Q9BV79 | |
| RGFTIESLVAKDGGT | 41 | Q04741 | |
| IRTVAEGKGDVILIG | 506 | O00423 | |
| EGKGDVILIGTTRNF | 511 | O00423 | |
| LGDRVLLDGQKTGTL | 296 | Q96DZ5 | |
| GSLKVGDRLLSVDGI | 191 | Q9C0E4 | |
| ELGVGDGVLLKAVAQ | 346 | P18858 | |
| NENTGGESVLGLLLK | 106 | Q16828 | |
| GELLLQRGTTKVATG | 191 | Q9H4I8 | |
| TLKLGISILNGGNAE | 3796 | P21817 | |
| LSDIFGLDLKREGGQ | 4376 | Q92736 | |
| DLSKLAEGEQILSGG | 81 | P30260 | |
| ELVSLQLKRGGGVGA | 741 | Q8NFZ4 | |
| IAGLTVLGTQDLGEK | 181 | P25940 | |
| GSLQLIQEGLKSGFL | 161 | Q8N3J2 | |
| IVEASSQKGRRGLGL | 116 | Q8N1G2 | |
| LKQLFIGSEGTLGII | 251 | Q8N465 | |
| LAKGLGAGVRTEADV | 366 | Q9BV36 | |
| KGQLGDAVSGTDVRI | 1046 | Q9UPQ0 | |
| GGQDDLLRLLITKGA | 611 | Q99549 | |
| EKQGDVILVSGIRTG | 211 | Q5VU65 | |
| LDNFIKIGEGSTGIV | 321 | O96013 | |
| LENLRLQKRGTGGVD | 346 | P17540 | |
| LLEGGSLGQLVKEQG | 471 | Q99558 | |
| RKLLDRGGEGLLSSQ | 921 | Q9BVI0 | |
| NERKGGILAIASLIG | 81 | P42345 | |
| SGLKEGLSLFGILNR | 246 | O43196 | |
| ELAVGREILKAGSIG | 716 | Q13233 | |
| REILKAGSIGIGGVD | 721 | Q13233 | |
| AEVREQLGKTGIAGS | 306 | Q13884 | |
| SLKVIGRGAFGEVRL | 91 | Q15208 | |
| RNIIKFTGSLILGGS | 31 | Q96JX3 | |
| QGELGFKEGDIITLT | 301 | Q99963 | |
| GARLLEKSGGLEIIF | 436 | Q7Z6J9 | |
| IGDKDVGRIVIGLFG | 46 | P45877 | |
| GVKRGSDELLSGSVL | 11 | Q9UKA9 | |
| LGGEGADVFVQILLK | 91 | Q5TGY1 | |
| ALQTVEKERGLGGEV | 116 | Q6UW68 | |
| IGVEGFGARELLKVG | 716 | A2VDJ0 | |
| GGVTESRGIVDSLQK | 16 | Q14DG7 | |
| LEQIGAEKLLSGTRD | 636 | Q6ZUX3 | |
| GIRLLSLGAGEFKSQ | 846 | P12259 | |
| LRLGEQEAKRNGTGI | 451 | P52294 | |
| NLVDLAGSERVGKSG | 671 | Q9BVG8 | |
| GIDKLVQGGGLDVLS | 956 | Q15788 | |
| AREVKLLLLGAGESG | 31 | P04899 | |
| LDGGVRTGNDVLKAL | 276 | Q9NYQ3 | |
| GIILAALGGDVEKRG | 2521 | P25391 | |
| GDTGVKLEVNERILG | 811 | O00291 | |
| RELEALLKEQGFGGV | 371 | Q02127 | |
| SVGEIITNIRKEDGG | 21 | Q96B97 | |
| LGGGDTVDSSIFRKL | 291 | O60292 | |
| GQTIGSVKQEGLERS | 561 | Q9UIU6 | |
| GASQGLLDRKEVLGG | 241 | P18827 | |
| LLDRKEVLGGVIAGG | 246 | P18827 | |
| GEIRRKTTLLLGQTG | 166 | Q8N8I0 | |
| RGFGIGSEILKNLSQ | 101 | P21673 | |
| LGVEELRGLKGFQFT | 1436 | O75592 | |
| GELINLQGKILSVDG | 431 | O00267 | |
| FILSDGEGKNGTIEL | 41 | P35244 | |
| LVQSGIKGGDERGLL | 271 | Q96QV1 | |
| RSGGTEGLLAEKLEA | 266 | Q9UHB9 | |
| GDLVIIGDRQLSKGT | 761 | Q5JTZ9 | |
| EAILGFTKDDGILGT | 36 | Q9Y2V3 | |
| KGLGSNERLEFIVST | 46 | Q08188 | |
| NGTLIESGIIGRSRK | 106 | P28288 | |
| GEGDFLVVGSIRKLA | 46 | Q9NY61 | |
| GITGQELERQLKESG | 281 | O00116 | |
| GLEQQLKETRGLVDG | 741 | Q9P2M7 | |
| LGQTGLGNIEELGKL | 286 | Q70JA7 | |
| GFLEQGILVVDKGRI | 91 | Q8IV77 | |
| KGVIDLAALGITGRQ | 816 | Q99570 | |
| LVDGRGTAFQGDKLL | 571 | Q12884 | |
| IGVKTRLDNGVTGFI | 1226 | Q7KZ85 | |
| LRVKIFLGGSEGTLN | 281 | Q96PU4 | |
| ALGEKTVFGQELRVG | 86 | P56706 | |
| LGVKGADIRDSGDLV | 581 | Q5T7W0 | |
| QGLDTSEGLLLFGKE | 2546 | Q8IZQ1 | |
| GKLFSGDELLEVNGI | 591 | O75970 | |
| LGLSIVGKRNDTGVF | 1736 | O75970 | |
| KEAGNLEGILLTGLT | 641 | Q9NXC5 | |
| IKDTLFNGLGLGAVI | 691 | O15394 | |
| GEGQSGLAVLKELLQ | 1521 | O60673 | |
| GAVILTIKAFDQIGG | 206 | A0PJK1 | |
| ELVLGTRDTGSKGVA | 946 | O75038 | |
| DLTKLLLEGQGESGG | 801 | P42226 | |
| TGDRLVKVNGESVIG | 116 | Q9P227 | |
| ATLLESIRQAGGIGK | 376 | A8MWX3 | |
| GGTGALILQKGEIRV | 756 | Q9Y5Y6 | |
| QEGSLLGKGETQGLL | 221 | Q8IX01 | |
| RKQISVRGLAGLGDV | 11 | P11216 | |
| ATLLESIRQAGGIGK | 361 | C4AMC7 | |
| VGLERQVSDLGSKGE | 466 | O95359 | |
| LVSGLRGLGVEIAKN | 76 | P22314 | |
| VGLKRGSDELLSSGI | 11 | O95758 | |
| GQTVLDGLEFKVALG | 1061 | O95347 | |
| RGLSDLQVGFGKQVD | 656 | Q9BZ95 | |
| LRVLGKLGEGALVND | 21 | A2A288 | |
| TELNGKTLGILGLGR | 141 | O43175 | |
| LQGKTLSQDEGRGTL | 611 | Q9HAU0 | |
| KTGLTENVDRGLGGL | 2106 | Q5VUA4 | |
| EAGKALLGLVQDVIG | 486 | Q70J99 | |
| TLLESIRQAGGIGKA | 346 | Q9NQA3 | |
| LGGVFQLEKGDRLSA | 196 | P01375 | |
| GVETGGKLLVSNLDF | 101 | Q86V81 | |
| LTRNGGTFEKQIGEV | 96 | P78423 | |
| GDSLGILQRKIDGTT | 26 | Q8NDX2 | |
| LEGLVRGLKAGVLSQ | 16 | P61421 | |
| VRLEGGIGLSLINKV | 3831 | Q5THJ4 | |
| GLLNDVSEGVTGLIK | 4076 | Q5THJ4 | |
| ILGVVGGTLKDFLNS | 151 | Q02108 | |
| GQGGREKLELVLSNL | 366 | Q96CT2 | |
| GALIVLEGVDRAGKS | 6 | P23919 | |
| LDGSERKVLINTDLG | 1501 | O75096 | |
| RIKIVEGLTFQGLDS | 226 | O94898 | |
| VDGILSEDKLTIGGI | 146 | O96009 |